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Porphyromonas gingivalis is a black-pigmented, anaerobic Gram-negative 
bacterium that is important in the progression of chronic and severe periodontitis. P. 
gingivalis has an essential requirement for iron, which is usually obtained in the form 
of heme. Iron/heme has been known to play important roles in the regulation of genes, 
important for the growth and virulence of this organism. Since P. gingivalis does not 
produce siderophores and has an incomplete set of genes required for the biosynthesis 
of protoporphyrin IX (the precursor of heme), heme must be acquired from exogenous 
sources.  
Various hemin-binding proteins have been characterized in this organism, of 
which, HmuR (encoded by hmuR) is found to be an important TonB-linked outer 
membrane receptor for hemin and hemoglobin uptake. As these hemin-uptake 
proteins do not usually work alone, the presence of a putative open reading frame 
(ORF) of hmuY, located upstream of hmuR, aroused our interest as little was known 
about this putative ORF.  
In this study, the presence of HmuY in P. gingivalis W50 was investigated 
using Western blot analysis with an antiserum specific to the peptide sequence of 
HmuY. This led to the discovery of a novel 24 kDa protein which possessed the same 
sequence as HmuY, but differs by having an additional string of 74 amino acids at the 
N-terminus. This protein was found to be encoded by a larger ORF that was 
overlapping and in-frame with hmuY. We have designated this new ORF as hmuY’. 
hmuY’ was found to be present abundantly as a transcript encoding itself with 
the overlapping hmuY, but without the downstream hmuR or any upstream genes via 




but no alternative transcripts of hmuY could be detected. hmuY’ was also found to be 
regulated mainly by the growth phase and is down-regulated towards the late growth 
phases.  
Functional characterization of P. gingivalis HmuY’ was also carried out in this 
study using recombinant proteins expressed in E. coli, as well as, successful 
construction of a P. gingivalis W50 isogenic mutant, PgY’1, which is defective in 
hmuY’. Recombinant HmuY’ was found to possess stronger hemin-binding ability 
than HmuY, using the LDS-PAGE and TMBZ staining assay. In P. gingivalis, 
HmuY’ was found to be important for growth especially under hemin-limited 
conditions. Finally, using immunogold-labeling and transmission electron microscopy, 
HmuY’ was found to be localized to the outer membrane surface of P. gingivalis 
whole cells. In summation of the results of this study, HmuY’ is proposed to be a 
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Chapter 1 Introduction 




Porphyromonas gingivalis is a black-pigmented, anaerobic gram-negative 
bacterium, important in the progression of chronic and severe periodontitis (Holt et al., 
1988). For successful colonization and establishment of an infection, the ability of a 
pathogen to scavenge essential nutrients within the environment is crucial. Iron, 
usually obtained in the form of heme, plays a vital role in the regulation of various 
genes and is essential for the growth and virulence of P. gingivalis (Bramanti and 
Holt, 1991; Genco, 1995; Kesavalu et al., 2003; McKee et al., 1986). Since genes 
required for the biosynthesis of protoporphyrin IX (the precursor of heme) are absent 
from the bacteria (Nelson et al., 2003; Schifferle et al., 1996), heme must be acquired 
from exogenous sources. Iron and heme are usually found complexed to host proteins 
including hemoglobin, hemopexin, haptoglobin-hemoglobin, albumin, lactoferrin and 
transferrin (Genco and Dixon, 2001; Genco et al., 1994). However, P. gingivalis does 
not produce siderophores that enable the bacteria to solublize the iron complexes 
(Nelson et al., 2003). Thus it has evolved various strategies to obtain iron/heme from 
these iron- and heme-binding proteins. These include production of proteases that 
degrade these proteins, as well as, production of lipoproteins, hemaglutinins and 
specific outer membrane receptors that bind directly to these heme-binding proteins 
(Olczak et al., 2005).  
Previously, HmuR, a Ton-B dependent outer membrane receptor, involved in 
hemin utilization was characterized in P. gingivalis A7436 (Liu et al., 2006; Olczak et 
al., 2001; Simpson et al., 2000; Simpson et al., 2004). Upstream of hmuR, a putative 
open-reading frame (ORF), hmuY, which is 429bp in length and found to be co-
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transcribed with hmuR was also identified (Simpson et al., 2000). Although HmuR 
has been described in detail, little is known about this upstream hmuY.  
The initial objective of this study was to characterize this putative ORF, hmuY. 
However, this led us to the discovery of an ORF that was overlapping and in-frame, 
but larger than hmuY. We designated this ORF as hmuY’. Thus, the main objective of 
this study was to characterize this novel ORF, hmuY’. Understanding the regulation 
and function of this novel ORF will give us a better understanding into the mechanism 





Chapter 2 Literature review 
Chapter 2  
Literature review 
2.1 Porphyromonas gingivalis and periodontal diseases 
Periodontal diseases are made up of a group of inflammatory diseases which 
involve the supporting tissues of the teeth. These can range from mild and reversible 
inflammation of the gingival (gum) to chronic destruction of the periodontal tissues 
(gingival, periodontal ligament and alveolar bone) which can lead to the eventual loss 
of teeth. They are prevalent in most human populations and can result in tooth loss in 
severely affected individuals. 
 
2.1.1  Bacterial etiology 
Studies conducted in the 1930s to 1970s were unable to identify specific 
bacteria as etiological agents of periodontal diseases. As such the “non-specific 
theory” was suggested which hypothesizes that periodontal disease is due to 
subgingival accumulation of microorganisms rather than the importance of any 
bacterial species as causative agents (Theilade, 1986). However, in the late 1970s and 
after, more specific microorganisms were isolated as etiological agents of 
periodontitis (Moore and Moore, 1994; Slots et al., 1986; Tanner et al., 1979). 
Eventually, sufficient experimental evidence was accumulated to designate 
Actinobacillus actinomycetemcomitans, Tannerella forsythensis (previously 
designated Bacteroides forsythus) (Sakamoto et al., 2002) and Porphyromonas 
gingivalis as primary etiological agents of periodontal diseases (Consensus report, 
1996). The focus of this study is on P. gingivalis, which will be the subject of further 




Chapter 2 Literature review 
2.1.2  Porphyromonas gingivalis 
Porphyromonas (formerly Bacteroides) gingivalis is a Gram-negative, 
coccobacillus, obligate anaerobic bacterium which is non-motile and forms black-
pigmented colonies on blood agar.  This organism has been shown to be present in 
higher numbers in diseased sites with periodontitis and in lower or non-detectable 
amounts in healthy gingival sites and plaque-associated gingivitis (Loesche et al., 
1985; Moore et al., 1991). 
It possesses various virulence factors that enable it to colonize and cause 
disease in humans by destruction of the gingival tissues and triggering inflammation 
and other immune responses. These virulence factors include gingipains, 
lipopolysaccharide (LPS), fimbriae, haemagglutinins and some outer membrane 
proteins (reviewed in (Lamont and Jenkinson, 1998)). 
 
2.2 Nutrient requirements of P. gingivalis 
2.2.1  Peptides 
In order for oral bacteria to establish themselves and thrive in the oral cavity, 
the ability to utilize available nutrients is crucial. P. gingivalis is an asaccharolytic 
organism, dependent on nitrogenous substrates for energy (Shah and Gharbia, 1989a). 
Among the potential nitrogenous substrates available, peptides are more efficiently 
utilized and are used in preference to amino acids (Shah et al., 1993). In the protein-
rich milieu of the oral cavity, action of proteolytic enzymes by P. gingivalis is thus 
important for its nutrient acquisition. Various proteases are produced by this organism 
to degrade potentially important substrates such as collagen, fibronectin, fribinogen, 
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2.2.2  Hemin 
P. gingivalis has an obligate requirement of iron for growth. This requirement 
is mainly satisfied by the utilization of hemin (iron protoporphyrin IX, Fig. 2.1A) 
which is usually obtained from the breakdown of hemin-containing compounds 
(hemoproteins) such as hemoglobin, haptoglobin, myoglobin and cytochrome C 
(Bramanti and Holt, 1991; Fujimura and Nakamura, 2000; Fujimura et al., 1995). 
Other sources of iron include transferrin and lactoferrin (de Lillo et al., 1996; Inoshita 
et al., 1991; Shizukuishi et al., 1995).Hemin is usually stored on the cell-surface as μ-
oxo dimers (Fig. 2.1B), which is believed to give rise to the characteristic black-
pigmented colonies (Smalley et al., 1998). 
Putative enzymes involved in porphyrin synthesis have recently been 
identified in strain W83: hemD (an uroporphyrinogen III synthetase), hemN (a 
coproporphyrinogen oxidase), hemG (a protoporphyrinogen oxidase) and hemH (a 
porphyrin ferrochelatase) (Nelson et al., 2003). Additionally hemG had been 
characterized experimentally in P. gingivalis 381 (Kusaba et al., 2002). However, 
presence of these enzymes are still not sufficient to allow proper heme biosynthesis. 
Since the genes required for the complete biosynthesis of heme are absent, P. 
gingivalis has to develop various strategies to scavenge iron from its surrounding 
environment, in order for it to obtain sufficient amounts to maintain its growth. 
 
2.3 Iron and heme availability in the host 
Iron, unlike other carbon and nitrogenous sources, is not a freely available 
nutrient in the human and other vertebrate hosts. It cannot be easily acquired from the 
host tissues and the surrounding milieu. At physiological pH, free iron exists mainly 
in its oxidized or Fe (III) form, which has a very low solubility of only 1.4x 10-9 M  
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Fig. 2.1 Structure of porphyrins. (a) The structure of protoporphyrin IX, which is 
made up of four pyrrole rings linked by four methane bridges. Fe2+ is added to the 
protoporphyrin via a ferrochelatase to yield heme. Substitution of the Fe2+ by other 
metals will give rise to other metalloporphyrins (not shown). (b) Heme refers to the 
reduced, or Fe (II), iron protoporphyrin IX while hemin refers to the oxidized, or 
Fe(III) form. The μ-oxo dimeric form of heme is made up of two heme moieties 
bridged by an oxygen atom. Figure is adapted from Olczak et al., 2005. 
6 
 
Chapter 2 Literature review 
(Chipperfield and Ratledge, 2000). This is far below the concentration of 10-7 M 
required to support bacterial growth. In addition to this insolubility, iron is not usually 
present in the free form. Majority of the iron in human is found complexed to host 
proteins such as hemoglobin, myoglobin, hemopexin, albumin, transferrin in serum, 
lactoferrin in extracellular fluids, and ferritin (Ratledge and Dover, 2000).  
Iron can be released in the form of heme from some host proteins (for e.g. 
hemoglobin and myoglobin) which are also known as hemoproteins. This heme can 
be used directly as an iron source by some pathogenic bacteria including P. gingivalis 
(Ratledge and Dover, 2000). Formally, the term ‘heme’ is used to refer to the reduced, 
or Fe2+, iron protoporphyrin IX (Fig. 2.1B) while the term ‘hemin’ refers to the 
oxidized form, or Fe3+, of iron protoporphyrin IX (Fig. 2.1B). Now ‘heme’ is widely 
used to refer to the iron protoporphyrin IX in either oxidation state.  
In aqueous solution in the absence of proteins and reducing agents, the iron 
protoporphyrin IX is found in its oxidized form (hemin). Free heme is toxic due to its 
oxidative nature, so, like iron, it is not allowed freely in aqueous solutions. When the 
heme-containing proteins are degraded, heme will be quickly bound by other proteins 
such as hemopexin and albumin (Tolosano and Altruda, 2002). With such heme-
scavenging proteins, the amount of free heme in the human host is maintained at very 
low levels.  
 
2.4 Mechanism of heme uptake in Gram-negative bacteria 
Since most of the iron and heme are complexed to these host proteins, many 
pathogenic bacteria have evolved various strategies for the release and utilization of 
heme from these host proteins. Three main mechanisms are employed by pathogenic 
































Fig. 2.2 Mechanisms for bacterial heme uptake. Red blood cells (RBC) are degraded by hemolysin to release heme and hemoglobin (Hb). Heme and 
hemoglobin is then transported into bacterial cell by several mechanisms: (A) Direct binding of Hb and heme to specific outer membrane TonB-linked 
receptors. Hb and heme are proposed to bind to specific sites on these receptors (HbR). (B) Capture of Hb and hemopexin by secreted proteins 
(hemophores) with high affinity for these substrates, which then delivers the substrate to a more specific receptor on the outer membrane which may be 
TonB-linked. The Hb receptor can bind either directly with the Hb substrate or via the hemophore. (C) Degradation of Hb and hemopexin by bacterial 
proteases, resulting in the release of heme. Bacterial proteases can be membrane-bound or secreted. Heme is taken up by heme receptors (HmR) or 
hemoglobin receptors (HbR). Energy for transport of iron or heme across the outer membrane is provided by TonB in association with ExbBand ExbD 
proteins. Transport across the cytoplasmic membrane occurs via an ABC transport system composed of a periplasmic binding protein (not shown), a 
permease and an ATPase. Within the cytoplasm, heme is broken down by heme oxygenase to release iron. Figure adapted from Genco et al., 2001.   
8
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The first mechanism involves direct contact of the hemoprotein with a specific 
TonB-linked receptor where specific sites on the receptor are used for substrate 
binding (Fig. 2.2A). The second mechanism involves synthesis of ultra-high affinity 
compounds, known as siderophores (hemophores if specific for heme), which are 
used to physically capture the substrates from the host by virtue of its superior binding 
strength, and delivers it to the cell (Fig. 2.2B). The last mechanism makes use of 
proteases to degrade the hemoproteins prior to uptake by hemin-binding proteins. The 
proteases can be secreted or membrane bound (Fig. 2.2C) (Genco and Dixon, 2001). 
As these iron complexes and heme are too large to enter through the outer 
membrane by diffusion via porins (pore-forming proteins), they need to be actively 
transported across the outer membrane through high-affinity transporters which utilize 
energy transduced from the electrochemical gradient across the cytoplasmic 
membrane. Energy for this transport is provided by the TonB proteins in association 
with ExbB and ExbD proteins (Braun, 1995). Receptors which require energy via the 
TonB system are named TonB-dependent or TonB-linked receptors and possess 
regions termed TonB boxes that mediate the interaction of these receptors with the 
TonB protein (Braun, 1995).  
Following this transport across the outer membrane, the iron complexes will 
need to be further transported across the cytoplasmic membrane into the cytoplasm 
before these compounds can be utilized. The transport of these iron compounds across 
the cytoplasmic membranes is usually mediated by proteins which belong to the 
family of ATP-binding cassette (ABC) transport system (Davidson and Chen, 2004). 
These ABC transport systems are usually made up of a soluble periplasmic subtrate 
binding protein, a permease and an ATP-binding protein with ATPase activity (Clarke 
et al., 2001).   
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2.5 Proteins in iron/heme uptake in P. gingivalis 
Since P. gingivalis are found to lack siderophores (Nelson et al., 2003), it is 
only able to obtain heme via the first and third mechanisms discussed above. Proteins 
involved in these uptake mechanisms are described below. 
 
2.5.1. Hemagglutinins and hemolysins 
Hemagglutinin proteins are well established virulence factors and help to 
promote colonization by mediating binding of P. gingivalis cells onto host cells. 
These proteins are also important in nutritional uptake by binding to erythrocytes and 
hemolysins serve to lyse these erythrocytes, thereby releasing heme (shah hn, gharbia, 
1989; decarlo aa, hunter n, 1999). Five genes are found to encode for these 
hemagglutinins in P. gingivalis: hagA, hagB, hagC, hagD and hagE (Lepine and 
Progulske-Fox, 1996; Progulske-Fox et al., 1989; Progulske-Fox et al., 1995). 
Expression of some of these genes was regulated by growth and hemin levels (Lepine 
and Progulske-Fox, 1996).  
Various hemolysins have also been identified (Chu et al., 1991; Deshpande and 
Khan, 1999; Karunakaran and Holt, 1993)) and some of these hemolysins have also 
been shown to be regulated by hemin levels (Chu et al., 1991). 
 
2.5.2. Gingipains 
Gingipains are one of the major and most important types of proteinases 
present in P. ginigvalis (Potempa et al., 2000). They are enzymes which belong to the 
family of cysteine-proteinases which include members such as papains, calpains, 
streptopains (from Streptococcus) and clostripain (from Clostridium)(Barrett and 
Rawlings, 2001). Gingipains are classified into two major types: (1) the arginine-
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specific gingipains (Arg-gingipains) and (2) the lysine-specific gingipains (Lys-
gingipain). The Arg-gingipains are encoded by the related genes rgpA and rgpB, and 
their products, HRgpA (95 kDa) and RgpB (50 kDa) respectively, both cleave peptide 
bonds specifically after arginine residues as their name suggests. The Lys-gingipain is 
encoded by the kgp gene and the product, Kgp, cleaves specifically after lysine 
residues.  
Gingipains are known to be involved in many functions for the pathogenesis 
of P. gingivalis (Imamura, 2003). Attachment and detachment of P. gingivalis to 
epithelial cells are also mediated by these gingipain adhesion and Rgp catalytic 
domains respectively (Chen and Duncan, 2004; Chu et al., 1991). The Arg-gingipains 
also play an important role in housekeeping by proteolytic processing and maturation 
of various fimbrillin, outer membrane proteins and proteases, including Kgp 
((Kadowaki et al., 1998; Nakayama et al., 1996)).   
In addition to its many functions mentioned above, gingipains are also found 
to be able to bind heme, protoporphyrin IX and other metalloporphyrins (Olczak et al., 
2001; Paramaesvaran et al., 2003). They are also able to degrade hemoglobin, 
haptoglobin, hemopexin, transferrin and lactoferrin (Dashper et al., 2004; Shah and 
Gharbia, 1989b; Smalley et al., 2004; Sroka et al., 2001). These abilities make 
gingipains key players in the acquisition of iron and heme. This heme uptake role of 
gingipains has been studied extensively by mutant analysis. Chen et al. (Chen et al., 
2000) isolated a non-pigmented mutant with a transposon Tn 4351 inserted within the 
kgp gene and found that it was unable to bind and degrade hemoglobin. Another rgpA 
rgpB kgp mutant was defective in growth when serum was present as the sole iron 
source (Shi et al., 1999). Also a non-pigmented mutant, MSM-3, had an insertion 
sequence element IS 1126 at the promoter region of kgp. This mutant was deficient in 
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Lys-gingipain activity and was also unable to utilize hemin and hemoglobin for 
growth (Simpson et al., 1999). Generally, mutants deficient in gingipains are found to 
be less or non-pigmented, suggesting the accumulation of iron/heme is greatly 
affected. Thus these results suggest the importance of these proteins in the acquisition 
of iron for growth.  
 
2.5.3. FetB (IhtB) 
Previously known as IhtB, FetB (Nelson et al., 2003) was first isolated as an 
antigenic 30 kDa protein (Pga30) (Hendtlass et al., 2000). Subsequently, this FetB 
(IhtB) protein was characterized to be a hemin-binding protein which was localized to 
the outer membrane (Dashper et al., 2000). Lipoprotein attachment sites were also 
found at the N-terminal sequence. Amino acid sequence analysis showed similarity to 
a Salmonella typhimurum cobalt chelatase, CbiK, protein and molecular modeling 
identified putative active-site residues critical for chelatase activity (Dashper et al., 
2000). Thus FetB (IhtB) has been suggested to be a peripheral outer membrane 
chelatase that may remove iron from heme prior to uptake by P. gingivalis. 
 The fetB(ihtB) gene is located in an operon that is predicted to encode an iron 
transport system, consisting of IhtA (a TonB-linked receptor), IhtC (a periplasmic 
binding protein), IhtD (a permease) and IhtE (an ATP-binding protein) (Dashper et al., 
2000). ihtCDE show similarity to typical ATP-binding cassette (ABC) transport 
systems in other bacteria. ihtAB is also proposed to be similar to transferrin uptake 
systems in Neisseria sp., which are composed of two components, a lipoprotein and a 
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2.5.4. Tla and Tlr proteins  
The Tla (TonB-linked adhesin) protein was first characterized in P. gingivalis 
W50 by Aduse-Opoku et al.(Aduse-Opoku et al., 1997). The N-terminal sequence of 
Tla was found to be similar to TonB-linked receptors frequently involved in transport 
of hemin, colicin, iron or vitamin B12, and the C-terminus was similar to the arginine-
specific protease. This protein was demonstrated to be important in hemin acquisition 
and utilization through mutant analysis. A mutant defective in the tla gene was unable 
to grow in medium with low concentrations of hemin (<2.5 mg/L) and hemin-
depleted cells of this mutant did not respond to hemin in an agar-plate diffusion assay 
(Aduse-Opoku et al., 1997). The mutants also showed lower levels of Arg- and Lys-
gingipain activities than the wild-type strain (Aduse-Opoku et al., 1997).  
In a later study, Slakeski et al. (Slakeski et al., 2000) screened a genomic 
library and found the tla gene to be different from that identified by Aduse-Opoku et 
al. (Aduse-Opoku et al., 1997). The sequence, designated tlr (TonB-linked receptor) 
by Slakeski et al.(Slakeski et al., 2000), was only similar at the N-terminus to TonB-
linked receptors and the C-terminus showed no homology to any gingipains, unlike 
tla. Moreover, only the tlr sequence could be found in the P. gingivalis W83 genome 
but not tla (Slakeski et al., 2000). Thus, Slakeski et al. (Slakeski et al., 2000) 
suggested that the tla sequence may be a result of a cloning artifact. 
The tlr gene was present downstream of an operon, htrABCD, that may encode 
a putative heme transport system, which was similar to other ABC transport systems 
(Slakeski et al., 2000). Sequence analysis predicted components of this system to 
contain a periplasmic-binding protein (HtrA), a permease (HtrB), an ATP-binding 
protein (HtrC) and HtrD was a hypothetical protein that did not show similarity to 
other known proteins.  
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2.5.5. RagA and RagB 
RagB protein was identified as a 55 kDa immunodominant antigen of P. 
gingivalis W50 (Hanley et al., 1999). ragA was an ORF identified upstream of ragB 
and both genes are found to be co-transcribed as a ragAB operon (Hanley et al., 1999). 
RagA was found to be similar to a TonB-linked receptor, at the N- and C-termini. 
RagB was classified as a lipoprotein based on the presence of a signal peptide of the 
lipoprotein type (Hanley et al., 1999).  
 The genetic arrangement of ragAB locus is also similar to those transport 
systems for transferrin and lactoferrin in Neisseria and Haemophilus sp. where a 
lipoprotein is usually co-transcribed with a TonB-linked receptor. This was similar to 
ihtAB (section 2.5.3). 
 
2.5.6. HemR 
The hemR gene was isolated and characterized in P. gingivalis ATCC 53977 
by sequencing the downstream portion of a fragment containing the prtT gene 
(Karunakaran et al., 1997). The HemR (48 kDa) protein showed similarity to TonB-
linked outer membrane receptors at the N-terminus and the C-terminus was found to 
be almost identical to the protease domain of P. gingivalis PrtT (Karunakaran et al., 
1997). A putative ORF, ORF1, was identified upstream of hemR in the same study.  
 Transcription regulation of hemR and orf1 was also investigated by Northern 
analysis. Results show ORF1 was transcribed as a 1.0 kb band and up-regulated under 
hemin-excess conditions. hemR was found to part of a 3 kb transcript which was up-
regulated under hemin-limited conditions and is suggested to be part of polycistronic 
mRNA but not with ORF1 (Karunakaran et al., 1997). Regulation of hemR was 
further confirmed by hemR:lacZ translational fusion (Karunakaran et al., 1997). 
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2.5.7. HmuY and HmuR 
The initial 1,050 bp of the hmuR gene was identified from a fragment of a 
cosmid library of P. gingivalis strain A7436. The 3’ end of the entire 1,941 bp DNA 
sequence was obtained following sequencing of a second clone (Simpson et al., 2000). 
HmuR (73 kDa) was found to be similar to TonB-linked receptors at the N-terminus 
and its ability to bind hemin and hemoglobin has been shown (Simpson et al., 2000). 
Regulation of hmuR was analyzed by RT-PCR and transcription was observed to be 
up-regulated under hemin-limited conditions (Simpson et al., 2000). Further, isogenic 
mutant of hmuR was created and demonstrated to have decreased ability to bind and 
grow with hemin and hemoglobin as the sole iron source (Olczak et al., 2001; 
Simpson et al., 2000; Simpson et al., 2004). More recently, specific residues have 
been identified in HmuR to be involved in heme utilization (Liu et al., 2006). Taken 
together, these data confirm the importance of this protein in iron/heme acquisition. 
A putative ORF, hmuY, was identified upstream of the hmuR gene and hmuY 
was found to be co-transcribed with hmuR by RT-PCR analysis (Simpson et al., 2000). 
Recently, recombinant HmuY was purified from E. coli as well as insect cells and 
preliminary characterizations demonstrated hemin- and ATP-binding abilities in these 
purified proteins (Olczak et al., 2006). 
 
2.5.7.1    HemR and HmuR 
  Comparison of hemR and hmuR sequences revealed hmuR to be identical to 
the first 516 bases of the hemR gene but no sequence homology was found after the 
516th base (Simpson et al., 2000). The hmuY sequence upstream of hmuR also showed 
99% sequence identity to that of ORF1 upstream of hemR (Simpson et al., 2000).  
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This difference was suggested to be a result of strain differences as slight 
variability was also observed in the carboxyl terminus of hmuR in some other strains 
tested (381 and W50)(Simpson et al., 2000). Such variability is suggested to be a 
result of genetic rearrangements facilitated by insertion elements (Simpson et al., 
2000). The sequence of hmuR was also found in the P. gingivalis W83 genome 
(Nelson et al., 2003) but not hemR.   
  
2.5.8. HBP35 (35 kDa protein) 
This 35 kDa protein was isolated by Western blot analysis using antiserum to 
the outer membrane fraction of P. gingivalis 381 and the gene, HBP35 encoding this 
protein was cloned (Abiko et al., 1990). HBP35 protein was found to function as a co-
aggregating factor toward Actinomyces viscosus and appears to confer colonizing 
ability to P. gingivalis (Hiratsuka et al., 1992).  
 Subsequently, this HBP35 protein was found to possess hemin-binding ability. 
The ability to bind PPIX and other metalloporphyrins were further tested and very 
low activity was found for these compounds (Shibata et al., 2003). This suggests that 
binding of metal protoporphyrins to HBP35 may be affected by different metal ions 
and that HBP35 may specifically select metal ions such as iron for binding and uptake. 
The Cys-Pro residues, common to a hemin-regulatory motif (HRM) with the 
consensus KCPVDH (Zhang and Guarente, 1995), was identified in the HBP35 
residue, YCPGGK. These Cys-Pro residues may serve to regulate the hemin-binding 
activities of these proteins by heme. 
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2.5.9. Other hemin-binding proteins 
Other than those proteins characterized in greater detail above, there are also a 
number of proteins that have been demonstrated to possess hemin-binding abilities 
but as their gene or amino sequences were incomplete or unavailable, these proteins 
were not further characterized.  
Kim and Holt (1996) isolated a 30 kDa (heated 24 kDa) hemin-binding cell 
envelope protein in P. gingivalis 381 (Kim et al., 1996). This protein was found to 
bind hemin by lithium dodecyl sulphate- polyacrylamide gel electrophoresis (LDS-
PAGE) and tetramethylbenzidine (TMBZ) staining, with increased binding under 
lower iron concentrations. Cyanogen bromide fragmentation of this protein showed 
peptides that were almost identical to segments of HmuY.  
Another 32 kDa hemin-binding protein was identified by (Smalley et al., 1993) 
using LDS-PAGE and TMBZ staining of heme binding proteins. This protein was the 
major hemin-binding protein (HBP) detected on the outer membranes (OM) when P. 
gingivalis W50 was grown under hemin-limitation. This and some other HBPs were 
only observed on the OM under hemin-limited conditions, which suggest that 
additional cell receptor system is required for hemin acquisition under low 
environmental hemin levels (Smalley et al., 1993). 
A 26 kDa outer membrane protein (OMP), Omp26, was revealed by I125-
autoradiography as the major OMP when P. gingivalis was grown under hemin-
limited conditions. This Omp26 was lost from the cell surface of P. gingivalis in 
response to environments containing iron, specifically hemin, indicating that it is a 
hemin-repressible protein (Bramanti and Holt, 1992a). Further characterization of this 
Omp26 discovered that it was heat modifiable (39 kDa unheated) and it was able to 
translocate across the OM, where it was associated with the cell outer surface under 
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hemin-limited conditions and buried in the deep recesses of the OM under hemin-
excess conditions (Bramanti and Holt, 1992b). Omp26 was also determined to be 
hemin-binding (Bramanti and Holt, 1993). However, neither the DNA nor amino acid 
sequence of this protein was determined throughout these studies. 
 
2.6 Regulation of genes involved in iron/heme utilization in P. gingivalis 
2.6.1  Ferric uptake regulator (Fur) 
Bacterial iron uptake systems are often regulated by the concentration of 
iron/heme in the surrounding environment (Litwin and Calderwood, 1993). Many of 
these genes involved in these iron uptake systems are under the control of the ferric 
uptake regulator (Fur) protein. Fur protein is made up of a DNA-binding domain at 
the N-terminus and a metal-binding domain at the C-terminus (Coy and Neilands, 
1991). The C-terminus is also involved in dimerization of the protein (Stojiljkovic and 
Hantke, 1995). Fur acts as a transcriptional repressor of iron-regulated promoters by 
virtue of its Fe2+-dependent DNA binding activity (Bagg and Neilands, 1987; Escolar 
et al., 1997). It binds to target DNA sequences known as Fur boxes (Escolar et al., 
1998). Under iron-rich conditions, the divalent ion binds to the Fur protein, allowing 
it to adopt a configuration that has high affinity for these Fur boxes and inhibits the 
transcription by preventing access of the RNA polymerase to the promoters of these 
genes which are repressed by the metal. Conversely, under low iron conditions, the 
equilibrium is displaced to release Fe2+, the RNA polymerase is allowed access to the 
promoters and transcription proceeds.  
Homologues of the fur gene have been identified in many Gram-negative 
pathogenic organisms such as Yersinia, Vibrio, Helicobacter pylori, Nesseria and 
Hemophilus (Bereswill et al., 1998; Carson et al., 1996; Litwin et al., 1992; Staggs 
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and Perry, 1991; Thomas and Sparling, 1994). Fur-like proteins have also been found 
in Gram-positive bacteria such as Bacillus subtilis and Staphylococcus (Bsat et al., 
1998; Heidrich et al., 1996). Most of these homologues are able to complement the E. 
coli fur mutant suggesting the similarity in the regulatory mechanisms shared by these 
microorganisms. A fur homologue has also been identified in P. gingivalis 
(AAQ65662), however, further characterization of this gene remains to be carried out.   
The consensus sequence of the Fur box in E. coli, 5’-
GATAATGATAATCATTATC-3’, contains a repeated consensus sequence of N 
ATA/TAT (Escolar et al., 1998). A sequence with 42 % homology to the E. coli Fur 
consensus was identified 90 bp upstream of P. gingivalis fur, suggesting possible 
auto-regulation of this protein. Another putative Fur consensus sequence was also 
identified upstream of the putative hmuY, showing 68 % similarity to the consensus. 
This may indicate the regulation of the hmuY and hmuR proteins by iron (Simpson et 
al., 2000). 
 
 2.6.2  LuxS 
Many bacteria populations are now known to intercommunicate and monitor 
their cell densities through release of specific signaling molecules known as 
autoinducers. This system of bacterial intercommunication is known as quorum 
sensing. Quorum sensing has been shown to be involved in regulation of many gene 
expressions (Bassler, 1999). The major types of quorum sensing systems are reviewed 
in (Reading and Sperandio, 2006).  
P. gingivalis has been described to possess the luxS gene and produces 
functional autoinducer, AI-2 (Burgess et al., 2002),(Chung et al., 2001). LuxS has 
been shown to regulate genes involved in stress responses (Yuan et al., 2005), as well 
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as genes involved in hemin acquisition (Chung et al., 2001),(James et al., 2006). The 
luxS mutant showed reduced transcription of genes coding for Tlr and Kgp, while up-
regulating genes coding for HmuR, FetB, FeoB1 and iron storage protein ferritin 
(James et al., 2006). These studies suggest the importance of LuxS in regulation of 
genes in P. gingivalis.  
 
 2.6.3  Other regulatory mechanisms 
The regulation of gingipains has been reported to be independent of iron or 
hemin levels. Analysis of P. gingivalis grown in various iron sources found that rgpA 
and kgp were regulated by growth phase, rather than by iron (Liu et al., 2004). kgp 
was also found to be down-regulated in the luxS mutant suggesting the regulation of 
some genes in P. gingivalis may be complex and multi-factorial.  
 
2.7 Importance of iron/heme in virulence of P. gingivalis 
The expression of many virulence factors has been associated with levels of 
iron/heme in P. gingivalis. Cells grown under hemin-limitation were shown to have 
increased hemagglutinating while those grown in hemin-excess showed increased 
hemin-binding activity and protease activity (Smalley et al., 1991). Production of 
significantly higher levels of trypsin-like protease activity was also observed under 
higher levels of hemin by Carman et al. (Carman et al., 1990). Hemin-excess media 
caused an increase in LPS antigenicity and an increased hemin-binding capacity of 
LPS (Cutler et al., 1996). Consistent with this, LPS of cells grown in hemin-normal 
conditions also demonstrated higher virulence by being a more potent neutrophil 
priming agent than LPS obtained from hemin-limited cultures (Champagne et al., 
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1996). Hemin-depletion was found to cause a reduction of gingipain activities as well 
(Kesavalu et al., 2003). 
 Other than the expression of virulence factors, various studies have also been 
carried out to investigate the more direct relationship between iron availability and 
virulence using animal models of infection. Generally, P. gingivalis cells were found 
to lose their virulence under conditions of hemin-limitation, so cells grown under 
hemin-excess conditions were found to be more virulent than those grown in hemin-
limitation (Kesavalu et al., 2003; Marsh et al., 1994; McKee et al., 1986; 
Papaioannou et al., 1991). 
Supporting the above studies, hemin-binding ability has also been correlated 
with virulence. Virulent strains are found to possess better hemin-binding ability and 
able to survive better under hemin-limitations than avirulent strains (Grenier et al., 
2001; Smalley et al., 1996), suggesting that hemin-uptake and availibility are crucial 
in determining the virulence of this organism. 
 Thus, the importance of iron/heme uptake is not only limited to the growth and 
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Chapter 3  
Materials and methods 
3.1 Media, Buffers and Solutions 
All growth media, buffers and solutions used in this study are listed in Appendix I. 
 
3.2 Bacterial Strains and Culture Conditions 
3.2.1     Bacterial Strains 
Porphyromonas gingivalis  
Strain W50 (ATCC 53978) was a generous gift from Dr. Alistair J. Lax 
(King’s College London). Bacteria identity was confirmed by distinct black 
pigmentation of the bacteria, Gram staining and the BBL Crystal Identification 
System (Becton Dickinson) (results not shown).  
Escherichia coli 
E. coli strain JM109 (Promega) was used as the host for the propagation of 
plasmid vectors and E. coli strain BL21(DE3) (Invitrogen) was used for the 
expression of recombinant proteins. 
The relevant characteristics of the bacterial strains used in this study are 
shown in Table 3.1. 
 
3.2.2      Culture of Bacteria 
P. gingivalis cultures 
P. gingivalis W50 was routinely cultured on Tryptic soy agar (TSA) with 5% 
sheep blood (Becton Dickinson), supplemented with 5 µg/ml hemin (Sigma), 1 mg/ml 
L-cysteine (Sigma) and 1 µg/ml menadione (vitamin K) (Sigma). It was subcultured 
every 3-5 days. For broth cultures, a single isolated colony was inoculated into 5 ml 
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of brain heart infusion (BHI) broth (Difco) supplemented with 0.5% yeast extract 
(Becton Dickinson), 5 µg/ml hemin, 1 mg/ml L-cysteine and 1 µg/ml menadione. 
This broth will be referred to, in this study, as standard Pg broth. Cultures were 
incubated anaerobically for 24-48 h and subcultured every 24 h.  
To look at effect of hemin-limitation, 24 h broth cultures of P. gingivalis were 
grown for two passages in hemin-free broth (BHI broth supplemented with 0.5% 
yeast extract, 1 mg/ml L-cysteine and 1 µg/ml menadione), each time with an initial 
OD600 of 0.1. Only cultures for the third passage in hemin-free broth were used for 
further analyses. These are referred to as hemin-limited cultures in this study. 
All P. gingivalis cultures were incubated anaerobically at 37oC in a Concept 
Anaerobic Workstation (Ruskinn Technology, UK) with an atmosphere of 80% N2, 
10% CO2 and 10% H2. All broths were pre-reduced for at least 24 h in the anaerobic 
workstation, prior to use, to remove traces of oxygen.  
 
E. coli cultures 
E. coli JM109 and BL21(DE3) were maintained on Luria-Bertani (LB) 
(Invitrogen) agar at 37oC.  For broth cultures, E. coli were grown in LB broth for 16 h 
at 37oC, with shaking at 220 rpm. 
E. coli harboring plasmids are grown in LB agar and broth supplemented with 
the appropriate antibiotics as mentioned below (section 3.3). 
 
3.2.3      Long Term Storage of Bacterial Cultures 
For long term storage of bacterial cultures, 1 ml of pure broth culture was 
mixed thoroughly with an equal volume of sterile 50% glycerol and stored in aliquots 
of 500 μl in a cryovial (Nunc). Vials were frozen and stored at -80oC immediately. 
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3.3 Plasmid vectors 
The pGEM®-T vector (Promega) has an ampicillin resistance marker and was 
used for the maintenance of desired polymerase chain reaction (PCR) products to 
facilitate cloning. This vector is a high copy number vector with a 5’ T-overhang for 
easy ligation of PCR products containing a 3’ A-overhang (TA cloning). This vector 
possesses a coding sequence for the α-peptide of β-galactosidase which allows for 
preliminary identification of positive clones by blue-white screening.  Selection of 
clones harboring this plasmid were done on LB agar containing 100μg/ml ampicillin 
(Sigma) supplemented with isopropyl β-D thiogalactoside (IPTG) and X-gal. 
Plasmid pGEX-4T-1 (Amersham Biosciences) was used for the expression of 
recombinant proteins in E. coli. This vector allows for high-level expression of fusion 
proteins with a Glutathione S-transferase (GST) moiety at the amino terminus and the 
protein-of-interest at the carboxyl terminus. A lacIq gene is engineered into the vector 
to allow for inducible expression of the proteins by IPTG. The vector also contains an 
ampicillin resistance marker, which allows for the selection of clones harboring the 
plasmid on LB plates containing 100 μg/ml ampicillin. 
Plasmid pVA2198 was used for PCR of the ermF cassette for subsequent 
insertion of this cassette to create a mutant of P. gingivalis. This plasmid was a gift 
from Dr. Hansel M. Fletcher from Virginia Commonwealth University, USA. It 
contains an E. coli origin of replication, a spectinomycin resistance marker, an oriT, a 
Bacteroides origin of replication and an ermF-ermAM cassette. ermF is expressed 
only in Bacteroides or Porphyromonas spp. and confers resistance to either 
clindamycin or erythromycin at 5 μg/ml while ermAM is expressed only in E. coli and 
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confers resistance to erythromycin at 300 μg/ml. The plasmid was maintained in E. 
coli JM109 and selected in LB broth or agar with 25 μg/ml spectinomycin (Sigma). 
Relevant features of the plasmids and their recombinant constructs are listed in 
Table 3.2.  
 
3.3.1      Plasmid DNA extraction  
5 ml of fresh overnight cultures of E. coli JM109 harboring the desired 
plasmids were harvested by centrifugation at 5000 x g for 15 min. Cell pellets were 
then used for plasmid extraction using the QIAprep® Spin Miniprep kit (Qiagen) 
according to manufacturer’s recommendations. Plasmids were eluted with 50 μl 
Buffer EB (Qiagen) and stored at -20 °C. 
Plasmid DNA was quantitated following section 3.10. 
 
3.4 Production of HmuY antiserum 
A synthetic 14-mer peptide corresponding to the amino acid residues 53 to 65 
of HmuY from P. gingivalis strain A7436 (Genbank accession no. AAF07986),which 
is identical to that of P. gingivalis W83 (Genbank accession no. AAQ66587), a close 
relative of strain W50, was used to raise HmuY peptide-specific antiserum. The 
peptide, CYEMGPDGHQMEYEE, with an N-terminal cysteine residue for 
attachment, was synthesized commercially and conjugated to limulus polyphemus 
hemolymph (LPH) by BioGenes, GmbH, Germany. The antiserum was raised 
commercially by the same company by immunization of the peptides into white 
rabbits. Rabbits were bled after 4 immunizations and serum obtained was tested 
commercially for positive reaction to the peptides by enzyme-linked immunosorbent 
assay (ELISA).  
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Table 3.2. List of plasmids and constructs. 
 
Plasmid Description Purpose Source 
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Specificity of the antiserum was further determined in our laboratory using dot 
blot assay using the purified peptide as the antigen. Pre-immune serum and bovine 
serum albumin (BSA) were used as negative controls for the antiserum and antigen 
respectively.  
 
3.5 Preparation of P. gingivalis whole cell lysate for Western blot analysis 
P. gingivalis W50 was grown in standard Pg broth (section 3.2.2) for 24 h and 
harvested by centrifugation at 5000 x g for 20 min. Supernatant was removed and 
pellet was washed once in 1X phosphate-buffered saline (PBS).  
Pellet was then resuspended in 300 μl 1X PBS and cells were lysed by gentle 
sonication on ice. Sonication was carried out on a MSE Soniprep sonicator (Sanyo) 
with a 1/8 microtip probe. Five cycles of sonication was performed on ice at 8 μm 
amplitude and in short bursts of 10s with 20s pauses. Lysozyme was not used as the 
molecular weight of lysozyme is very similar to the predicted molecular weight of 
HmuY and thus may obscure presence of the HmuY protein.  
Cell lysates were then mixed with 6X SDS Loading Buffer (Appendix I) to a 
final concentration of 1X, and heated at 95°C for 5 min prior to loading onto the SDS-
PAGE gel. 
 
3.6 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
All protein samples were analyzed using a discontinuous SDS-PAGE system 
following the methods of Laemmli (Laemmli, 1970) using a 4% (w/v) acrylamide 
stacking gel and a 12% (w/v) acrylamide separating gel. Compositions of gels are 
listed in Appendix I. Gels were cast and run using a Mini-Protein II (Bio-Rad) gel set. 
Glass plates with 0.75 mm spacers were assembled according to manufacturer’s 
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instructions and the 12% separation gel was first poured in, taking care not to generate 
bubbles. Water-saturated butanol (Appendix I) was overlaid immediately on the gel to 
exclude air and the gel was allowed to polymerize for 30-45 min. After which, the 
water-saturated butanol was washed off with ddH2O and the 4% stacking gel was 
added with the comb inserted at the same time. Polymerization was allowed for a 
further 30 min. 
Protein samples and the Protein Molecular Weight Marker (Fermentas) were 
mixed with an appropriate amount of 6X SDS loading buffer (Appendix I), heated at 
95oC for 5 min to denature proteins and subsequently loaded into the wells. Gels were 
run in 1X Tris-glycine Buffer (Appendix I) at a constant voltage of 100 V for 
approximately 90 min or until the dye-front has reached the bottom of the gel. 
After the run, the gel was disassembled from the set-up and proteins were 
visualized with a commercially-prepared Coomassie-blue staining solution, BluePrint 
FAST-PAGETM (Gibco), according to manufacturer’s recommendations.   
  
3.7 Western blot analysis using the  HmuY peptide-specific antiserum 
Following separation on the SDS-PAGE, the gel was disassembled from the 
set-up and equilibrated in Transfer Buffer (Appendix I) for 20 min. Proteins were then 
transferred via electroblotting onto Hybond ECL nitrocellulose membranes 
(Amersham Biosciences) using a Mini-TransBlot assembly (Bio-Rad) following 
manufacturer’s instructions. The transfer was done in ice-cold Transfer Buffer at a 
constant voltage of 100 V for 2 h. Care was taken to prevent the temperature of the 
set-up from rising above 16oC, by replacing the ice-block every 45 min. 
After the transfer, the membrane was removed from the set-up and the lane 
with the protein marker was cut out. The marker lane was stained for 2 min in 
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Ponceau S solution (Appendix I) and washed with ddH2O to visualize the protein 
molecular weight markers, which also served as an indication of successful transfer. 
The remaining membrane (containing sample proteins) was blocked by incubation 
with 50 ml Blocking buffer (Appendix I) overnight at 4oC with gentle agitation. After 
which, the primary antibody, HmuY peptide-specific antiserum, was diluted 1:200 in 
Blocking Buffer and incubated with the membrane at room temperature for 2 h. 
Membrane was then washed 4 times of 15 min each with Wash buffer (Appendix I) at 
room temperature to remove excess primary antibodies. Secondary antibody, goat 
anti-rabbit IgG conjugated with alkaline phosphatase (AP), was diluted 1:4000 in 
Blocking Buffer and incubated with the membrane at room temperature for 2 h. 
Washing was done as before with Wash buffer for 4 times of 15 min each to remove 
excess secondary antibodies. All washes and incubations were done with gentle 
agitation. 
Bands were then visualized by chromogenic substrates, nitro blue tetrazolium 
(NBT) and 5-bromo-4-chloro-3-indolyl-phosphate (BCIP) (Promega).  
 
3.8 Mass spectrometry analyses of 24 kDa protein band 
The protein band of interest was excised from the Commassie blue-stained 
SDS-PAGE gel using a clean scapel. The band was then sent to the Proteins and 
Proteomics Centre, Department of Biological Sciences, National University of 
Singapore where in-gel reduction and alkylation, in-gel digestion (with trypsin) and 
matrix-assisted laser desorption ionization-tandem time-of-flight (MALDI-TOF-TOF) 
mass spectrometry analysis were performed by staff with technical expertise. Proteins 
were identified from the peptide mass spectrum using automated database searching 
with the search engine Mascot (Matrix Science). 
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3.9 Genomic DNA extraction 
P. gingivalis was grown in 5 ml of standard Pg broth (section 3.2.2) for 24 h 
and harvested by centrifugation at 5000 x g for 20 min. The supernatant was removed 
and the pellet resuspended in 1 ml DNAzol® Genomic Isolation reagent (Invitrogen). 
The DNAzol®  works based on the use of guanidine-detergent lysis solution that 
allows for the selective precipitation of DNA. After addition of DNAzol®, the cell 
lysate was centrifuged to remove cell debris and the supernatant transferred to a fresh 
microcentrifuge tube. DNA was precipitated by addition of one volume of absolute 
ethanol. Precipitated DNA was spooled and washed in 70% ethanol twice. 
Precipitated DNA was collected by centrifugation and the 70% ethanol was removed 
as much as possible. The DNA pellet was then air-dried, resuspended in autoclaved 
ddH2O and kept at 4°C for short term storage or -20°C for long term storage.    
 
3.10 Quantification of DNA 
All DNA samples were quantified and assessed for purity using the 
NanoDrop® ND-1000 spectrophotometer (NanoDrop Technologies). Absorbance 
readings were taken at 260nm for quantification and purity of the DNA was assessed 
by the ratio of absorbance at 260nm and 280 nm (OD260/OD280). A ratio of 1.7-1.9 
shows the DNA was pure with little protein contamination. Quantification of DNA is 
based on the relationship that 1 OD260 = 50 μg/ml DNA, thus:  
Concentration of DNA (μg/ml) =  OD260 X dilution factor X 50. 
In addition, an aliquot of genomic DNA was analyzed on a 0.8% agarose gel 
by agarose gel electrophoresis to check for the integrity of the extracted DNA. A 
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distinct band of high molecular weight indicates the genomic DNA was intact with no 
degradation. 
 
3.11 Agarose Gel Electrophoresis 
DNA samples were analyzed on a 1% agarose gel unless otherwise stated. 
Agarose was mixed with 1X TAE buffer (Appendix I) to a concentration of 0.8% or 
1% and dissolved by heating in a microwave. The molten gel was cooled to 55oC 
prior to pouring it into a gel tray set-up in the Horizon® 58 Horizontal Gel 
Electrophoresis apparatus (Whatman Biometra). DNA samples were mixed with 6X 
Agarose Gel Loading Buffer (Appendix I) to a final concentration of 1X prior to 
loading, and the 2-log DNA ladder (NEB) was used as the DNA standard. 
Electrophoresis was carried out in 1X TAE buffer at constant voltage of 5 V/cm using 
a Bio-Rad Power Pac 300. The run was terminated when the bromophenol blue dye-
front had migrated across approximately two-thirds of the full gel length. After which,  
the gel was stained with 0.5 μg/ml of ethidium bromide (EtBr) in 1X TAE buffer for 
10 min and visualized under UV. Gel image was captured with the Gel 
Documentation System (Gene Genius, Syngene). 
 
3.12 Polymerase Chain Reaction (PCR) 
Amplifications of gene sequences for probes and cloning were all carried out 
using Pfu DNA Polymerase (Promega). Typical PCR reactions with Pfu DNA 
Polymerase contained final concentrations of 1X Pfu DNA Polymerase buffer with 
MgSO4, 0.4 μM of each forward and reverse primers, 200 μM of each dNTP, <0.5 μg 
of DNA template and 0.5 μl of Pfu DNA Polymerase (2-3 units/μl) in a 50 μl reaction.  
Typical amplification conditions used are: initial denaturation at 95°C for 3 min, 
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subsequent cycles of denaturation at 95°C for 1 min, annealing temperature at 50-
55°C for 1 min and extension at 72°C for 2-4 min, for 25-30 cycles.   
PCR reactions used for screening of clones and other amplification reactions 
(unless otherwise stated) were performed using Taq DNA Polymerase (Promega). 
Typical PCR reactions with Taq DNA Polymerase contained final concentrations of 
1X Taq DNA Polymerase buffer, 2.5 mM of MgCl2, 0.2 μM of each forward and 
reverse primers, 200 μM of each dNTP, <0.5 μg of DNA template and 0.5 μl of Taq 
DNA Polymerase (5 units/μl) in a 50 μl reaction. Amplification conditions are: initial 
denaturation at 95°C for 3 min, subsequent cycles of denaturation at 95°C for 30-45 s, 
annealing temperature at 50-55°C for 30-45 s and extension at 72°C for 1-3 min, for 
25-30 cycles. 
 All PCR reactions were carried out using the iCycler (Bio-Rad). 
 
3.12.1     Addition of 3’ A-overhangs post-PCR 
PCR products are usually cloned into TA-cloning vectors like pGEM-T for 
easy maintenance. This requires a 3’A-overhang on the PCR product. However, 
products amplified with Pfu polymerase lack this 3’A-overhang due to the lack of the 
terminal transferase activity associated with the proof-reading polymerases. To add a 
3’ A-overhang, PCR products were purified using QIAquick® PCR Purification kit 
(Qiagen) to remove Pfu DNA polymerase. Purified PCR products were then incubated 
with 1X Taq DNA polymerase buffer with 25 mM MgCl2, dATP, and 2 units of Taq 
DNA polymerase (Promega) at 72°C for 15 min. These products are then ligated into 
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3.13 PCR of probes for Southern and Northern blot analyses 
3.13.1    Probes for hmuY’ and hmuY 
DNA probes specific for hmuY’ and hmuY were obtained from P. gingivalis 
genomic DNA by PCR using the primer pairs ProbeY’_Fwd/ProbeY’_Rev and 
ProbeY_Fwd/ProbeY_Rev (Table 3.3) respectively with Pfu DNA Polymerase 
(Promega) to ensure high fidelity. PCR products were visualized by agarose gel 
electroporesis (according to section 3.11) to check for specific amplification and 
products were purified using Qiaquick® PCR Purification Kit (Qiagen) prior to 
labeling.  
These probes were used for both Southern and Northern blot analyses and 
labeled respectively (see sections 3.14.5 and 3.19.4). 
 
  3.13.2     Probe for ermF 
DNA probe specific for ermF was obtained from PCR of pVA2198 using the 
primer pairs ermF_ClaI_Fwd/ermF_ClaI_Rev (Table 3.3) with Pfu DNA polymerase 
(Promega) to ensure high fidelity. PCR product was visualized by agarose gel 
electroporesis to check for specific amplification and products were purified using 
Qiaquick® PCR Purification Kit (Qiagen) prior to labeling. 
 
3.14 Southern blot analysis of P. gingivalis 
3.14.1    Separation of DNA 
P. gingivalis genomic DNA was digested with BamHI (NEB). 5 μg of digested DNA 
was loaded per well on a 1% TAE agarose gel and 5 μl of DIG-labeled DNA 
molecular weight marker II (Roche) was run alongside. Electrophoresis was 
performed at 90 V for 40 min. DNA bands were visualized by staining the gel in   
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Table 3.3. Primers used in this study.  
   
Primer1 Sequence2 Description 
ProbeY’_Fwd 5’-ATGAAAAAAATCATTTTCTCCGC-3’ 
ProbeY’_Rev 5’-GAAGAGCCATGTCCCAGTTCAAA-3’ 
Amplifies DNA probe specific for hmuY’ for 
Southern and Northern hybridizations 
ProbeY_Fwd 5’-ATGGATCAGGCTACTACCGT-5’ 
ProbeY_Rev 5’- TTATTTAACGGGGTATGTATAAG-3’ 
Amplifies DNA probe specific for hmuY for 
Southern and Northern hybridizations 
hmuY’_Fwd 5’-ATGAAAAAAATCATTTTCTCCGC-3’ 
hmuY’_Rev 5’-TTATTTAACGGGGTATGTATAAG-3’ 
Amplifies entire 651 bp hmuY’ gene 
hmuY’_BamHI_Fwd 5’-CCGGGATCCATGAAAAAAATCAT-3’ 
hmuY_XhoI_Rev 5’-AATCTCGAGTTATTTAACGGGGTA-3’ 




Amplifies entire 429bp hmuY gene for cloning 
into pGEX-4T-1 
ermF_ClaI_Fwd 5'- CCATCGATGGGATAGCTTCCGCTATTGC-3' 
ermF_ClaI_Rev 5'-CCATCGATTCCATCGCCAATTTGCC-3' 
Amplifies entire ermF cassette with its flanking 
sequences for cloning into ClaI site of hmuY’ 
hmuY’_Rev_6FAM 5’-(6-FAM)TCAATGGCAATGCACAGAG-3' 6-FAM-labeled reverse primer specific for hmuY’sequence 




ethodsCont’d next page… 
35 
Table 3.3. (Cont’d) Primers used in this study.  
Pm1_Fwd 5’-ACCTATTAAAAGTAAGGTCAG-3’ Forward primer beginning with mapped transcriptional start site at 5’ end 
Pm2_Fwd 5’-GAACATCTCAACTTTGCAGC-3’ Forward primer targeting gene sequence outside of putative transcriptional start site 
pGEMT_M13_Fwd 5'-GTTTTCCCAGTCACGAC-3' 
pGEMT_M13_Rev 5'-CAGGAAACAGCTATGAC-3' 
Sequencing primers for pGEM-T clones 
pGEX-Fwd 5'-GGGCTGGCAAGCCACGTTTGGTG-3' 
pGEX-Rev 5'-CCGGGAGCTGCATGTGTCAGAGG-3' 
Sequencing primers for pGEX clones 
hmuY’_5'UTR 5'-ATCGAGGGCTTTTTCATGTG-3' Primer targeting 156 bp upstream of hmuY’ ORF 
hmuY’_3'UTR 5'-ACGATGGTGTCGGTAGGTTG-3' Primer targeting 139 bp downstream of hmuY ’ORF 
   
1Fwd, forward; Rev, reverse  
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 0.5 μg/ml ethidium bromide and examined under UV. The gel was then used for 
transfer onto nylon membrane. 
 
             3.14.2     Denaturation of DNA prior to transfer 
DNA in the agarose gel was first denatured to obtain single-stranded DNA, by 
submerging the gel in Denaturation Solution (Appendix I) for 2 changes of 15 min 
each at room temperature and with gentle agitation. Care was taken not to allow this 
incubation to proceed for longer than a total of 30 min as the DIG-labeled DNA 
marker is alkaline labile.  The gel was then rinsed briefly in ddH2O before 
submerging it in Neutralization Solution (Appendix I) for 2 changes of 15 min each at 
room temperature. The gel was finally allowed to equilibrate in 20X SSC (Appendix I) 
for 10 min prior to transfer. 
 
3.14.3    Transfer of DNA onto nylon membrane 
The transfer assembly was set-up following Fig. 3.1. First, a piece of 
Whatman 3MM paper soaked with 20X SSC was placed on a platform (bridge) 
resting in a shallow reservoir of 20X SSC. The gel was then placed on top of this 
soaked filter paper, taking care not to trap any air bubbles between the gel and paper. 
Cut a piece of Hybond N+ nylon membrane (Amersham Biosciences) to the size of the 
gel and place the dry membrane on top of the gel, removing any air bubbles by rolling 
a clean pipette over the sandwich. Place another dry Whatman 3MM paper on top of 
the membrane, followed by a stack of dry paper towels. Complete the assembly by 
placing a glass plate on top of the sandwich, followed by a weight of 200-500g. 
Plastic wrap can be placed over the entire set-up to reduce evaporation of the reservoir. 
The blot was then allowed to transfer overnight at room temperature in 20XSSC.
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Fig. 3.1.  Set-up for transfer of DNA onto membrane for Southern blot analysis 
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3.14.4      Fixing of DNA onto membrane 
After the transfer, disassemble the set-up and briefly rinse the membrane in 
2X SSC to remove agarose gel bits. While the blot is still damp, the DNA was cross-
linked using a UV Stratalinker 3500 (Stratagene) at 1200 mJ and membrane was 
allowed to air dry. The dry membrane can be stored at 4oC in a sealed bag if not used 
immediately. 
 
3.14.5   Labeling of probes for Southern blot analysis  
Labeling of probes for Southern blot analysis was carried out using the DIG 
High Prime DNA Labeling and Detection Starter kit I (Roche) following 
manufacturer’s recommendations. 
Briefly, 1 μg of template DNA (purified PCR products) was diluted in ddH2O 
to a final volume of 16 μl and denatured in a boiling water bath for 10 min. The 
denatured DNA was then quick-chilled in an ice-water bath and 4 μl of DIG-High 
Prime (containing random hexamers, dNTP mix with Digoxigenin-11-dUTP, Klenow 
enzyme and optimized reaction buffer) was added and mixed thoroughly. The mixture 
was incubated at 37°C overnight and reaction was stopped by adding 0.2 M EDTA  
and by heating to 65°C for 10 min.   
Labeling efficiency was determined following the protocol in the DIG High 
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             3.14.6     Hybridization of probes  
The appropriate hybridization temperature (Thyb) was determined for each 
probe using the formulas:  
Tm = 49.82 + 0.41 (% GC) – (600/l) [l = length of hybrid in bp]  
Thyb = Tm – 20 to 25°C   
Pre-hybridization and hybridization of probes were carried out using DIG 
Easy Hyb (Roche) using heat-sealable bags in a shaking water bath. For pre-
hybridization, membrane was incubated with DIG Easy Hyb for 30 min at Thyb.  
For hybridization, appropriate amounts (~25 ng/ml) of DIG-labeled probes 
were denatured by boiling at 95°C for 5 min, quick-chilled in an ice-water bath and 
then mixed with the DIG Easy Hyb. Membrane was then incubated with this mixture 
at Thyb overnight to allow hybridization. 
 
 3.14.7     Post-hybridization washes 
 Following hybridization, the blots were washed twice in 2X SSC, 0.1% SDS 
for 5 min each, at room temperature and with gentle agitation. This was followed by 
two washes in 0.5X SSC, 0.1% SDS for 15 min each, at 65°C to remove non-specific 
hybridizations.   
 
3.14.8        Detection of probes  
Washing and immunodetection of blots were carried out using the DIG High 
Prime DNA Labeling and Detection Starter kit I (Roche) following manufacturer’s 
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3.15 RNase control 
To ensure good preparations of RNA, steps were taken to prevent introduction 
of RNases, which are omni-present in the environment, on our skin and in the air, into 
our RNA preparations. Gloves were worn at all times during preparation of samples, 
reagents and materials for RNA work. Sterile RNase-free certified microcentrifuge 
tubes (Axygen) and sterile RNase-free filtered-tips (Axygen) were used for all 
samples preparations. Prior to use, pipettors, gel tanks and glasswares were treated 
with RNaseZap® (Ambion). Whenever possible, all solutions used were prepared 
using diethyl pyrocarbonate (DEPC)-treated water. DEPC-treated water was prepared 
by incubating ddH2O with 0.1% DEPC overnight at 37°C to inactivate RNases 
present, followed by autoclaving at 121°C for 30 min to completely remove residual 
DEPC.   
 
3.16 RNA extraction  
Total RNA was extracted from P. gingivalis W50 cells. Cells were harvested 
by centrifugation at 5000 x g for 20 min. Cell pellet obtained per 20 ml culture was 
resuspended and lysed with 1ml of RNAzol®. Transfer the lysed cells to a fresh 
microcentrifuge tube and allow incubation at room temperature for 10 min to allow 
dissociation of nucleoproteins. 200 μl of chloroform was then added and the tube was 
shaken vigorously for 1 min prior to incubation for 5 min at room temperature. The 
aqueous phase, which contains the RNA, was separated from the organic phase, 
which contains cellular proteins and unbroken cells, by centrifugation at 10 000 x g 
for 15 min. The aqueous phase was then transferred to a fresh tube without disturbing 
the interphase, which contains DNA. RNA was precipitated by 1 ml of isopropanol 
followed by centrifugation to pellet the RNA. The RNA pellet was then washed in 
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75% ethanol. The resulting RNA pellet was re-dissolved in DEPC-treated water and 
stored at -80°C. 
 
3.17 DNase treatment of total RNA 
Total RNA samples were all treated with DNase to remove contaminating 
DNA prior to further analyses. 10 μg of RNA was treated in a 50 μl reaction with 2 
units of TURBO DNase (Ambion) at 37°C for 1 h.  
 
3.18 Quantification of RNA 
 RNA samples were quantified and assessed for purity using the NanoDrop® 
ND-1000 spectrophotometer (NanoDrop Technologies) similar to that for DNA (see 
section 3.10), except that quantification of RNA is calculated by: 
  Concentration of RNA (μg/ml) = OD260 X dilution factor X 40 
 An OD260/OD280 ratio of 1.9-2.0 was obtained for all the samples, indicating that the 
RNA samples were pure without contamination of proteins. 
. 
3.19 Northern blot analysis 
3.19.1      Separation of RNA 
6.5 μg of total RNA from each sample was separated on a 1% agarose gel 
prepared using the commercially available 10X Gel Prep/Running Buffer from the 
NorthernMax-Gly® kit (Ambion). This kit uses the glyoxal/dimethylsulfoxide(DMSO) 
method to denature the RNA where the denaturant is present in the loading buffer 
instead of the gel. Compared to the MOPS/formaldehyde method, this method 
provides the advantage that a fume hood is not required to run the gel, so exposure to 
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obnoxious formaldehyde fumes is avoided. The 10X Gel Prep/Running Buffer in the 
kit provides further advantage of eliminating the need for recirculation of the buffer 
during electrophoresis which is the major disadvantage with standard protocols for 
running glyoxal gels.  
Samples were mixed with an equal volume of 2X Glyoxal Loading Dye 
(NorthernMax-Gly® kit, Ambion) and heated at 50°C for 30 min to denature the 
secondary structure of RNA prior to loading. Gels were then electrophoresed in 1X 
Gel Prep/Running Buffer provided in the kit at a constant voltage of 5 V/cm, until the 
bromophenol blue dye front was approximately 3 cm from the bottom of the gel tray. 
Gels were visualized under UV before transfer and a piece of plastic wrap was placed 
beneath the gel to prevent possible contamination of the gel with RNase on the 
surface of the transilluminator. Integrity of the RNA was determined from the distinct 
and sharp bands of the 23S and 16S ribosomal RNA (rRNA), which indicates that the 
RNA is not degraded.  
  
3.19.2       Transfer of RNA onto membrane 
Protocol for transfer was adapted from the NorthernMax-GlyTM kit (Ambion). 
RNA was transferred onto BrightStar-PlusTM (Ambion) positively-charged nylon 
membranes using a downward capillary transfer following the set-up in Fig. 3.2.   
A stack of dry paper towels (~3 cm high) was pre-cut to a size slightly larger 
than the gel and placed beside the Transfer Buffer (Appendix I) reservoir. 3 pieces of 
dry Whatman 3MM paper was placed on top of the towels, followed by 2 more pieces 
of Whatman 3MM paper wet in Transfer Buffer, all of which were trimmed to the gel 
size. Next, the nylon membrane was also trimmed, wet briefly in Transfer Buffer and 
placed on top of the stack. The gel was then positioned in the centre of the membrane, 
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Fig. 3.2. Set-up for transfer of RNA onto membrane for Northern blot analysis 
(downward capillary transfer). Figure adapted from NorthernMaxTM-Gly 
Instruction Manual (Ambion). 
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taking care to avoid trapping bubbles between the gel and membrane. 3 more pieces 
of trimmed Whatman 3MM paper wet in Transfer Buffer were then added on top. 
Finally, filter paper bridges large enough to cover the gel and reach across to the 
Transfer Buffer reservoir were wet and placed on top of the sandwich, with one end in 
the Transfer Buffer reservoir. To complete the set-up, a small weight of 150-200 g 
was placed on a plastic cover and added on top of the stack to ensure even contact of 
all the stack components. 
Transfer was allowed to proceed for 2 h at room temperature.  
 
3.19.3       Fixing of RNA onto membrane 
After the transfer, the membrane was rinsed briefly in 1X Gel Running Buffer 
to remove salts and agarose bits. To crosslink the RNA to the membrane, the 
membrane was exposed to a handheld UV light source with wavelength 254 nm for 
45 s, and microwaved at high for 1 min (Angeletti et al., 1995). Membrane can be 
dried and stored at -20 °C if not used immediately. 
 
  3.19.4        Labeling of probes for Northern blot analysis 
 DNA probes specific to hmuY’ and hmuY were prepared by PCR following 
section 3.13.1.  PCR products were also purified using PCR Purification kit (Qiagen). 
 Purified DNA probes were labeled using BrightStarTM Psoralen-Biotin 
Nonisotopic Labeling Kit (Ambion) following manufacturer’s recommendations. This 
kit uses the intercalating property of psoralens to efficiently label nucleic acids with 
biotin using a Psoralen-Biotin conjugate. Psoralens intercalate between nucleic acid 
bases and upon irradiation with long wavelength UV (365 nm), becomes covalently 
attached to the nucleic acid.  
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3.19.5      Prehybridization   
Membrane was prehybridized with pre-warmed ULTRAhybTM Ultrasensitive 
Hybridization buffer (Ambion) in a heat-sealable bag at 42°C for 45 min. 
 
3.19.6       Heat Denaturation of Psoralen-Biotin-Labeled Probes and 
Hybridization  
5 μl of each Psoralen-Biotin labeled DNA probe was diluted in 45 μl 10 mM 
EDTA (Appendix I) to obtain a final concentration of  ~10 ng/ml. The diluted probe 
was then incubated at 90°C for 10 min to denature the double-stranded DNA.  The 
denatured probe was then added immediately to the same ULTRAhybTM buffer used 
for prehybridization, at a final concentration of ~ 1 ng/ml, and mixed quickly 
thoroughly.  
Hybridization was carried out 42oC for 16 h.  
 
3.19.7  Post-hybridization washes 
  Membrane was washed once with Low Stringency Wash Solution (Appendix 
I) for 10 min at room temperature to remove excess ULTRAhybTM buffer. This was 
followed by two washes with High Stringency Wash Solution (Appendix I) at 42oC 
for 15 min each which removes excess probes.   
 
3.19.8 Detection of probes 
Immunodetection of the probes was carried out using the BrightStarTM 
BioDetectTM Nonisotopic Detection Kit (Ambion) following manufacturer’s 
recommendations. This kit uses strepavidin conjugated with alkaline phosphatase and 
substrate, CDP-Star, for the chemiluminescent detection of biotinylated DNA probes. 
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Membranes were exposed to Kodak film and developed. 
 
3.20 cDNA synthesis (Reverse transcription) 
1 μg of DNase-treated RNA was used for reverse transcription with 20 pmol 
of gene-specific reverse primer, 10mM dNTP, 40 units of RNase inhibitor 
(Fermentas), 200 units of RevertAidTM H minus MMLV Reverse Transcriptase 
(Fermentas) and 1X reaction buffer in a volume of 20 μl. Negative control was 
prepared similarly but without reverse transcriptase. The negative control serves to 
ensure that the RNA samples were free of genomic DNA contamination.  
cDNA synthesis was allowed to proceed at 42oC for 1 h, after which reverse 
transcriptase was denatured at 70oC for 10 min. Subsequently, PCR may be performed 
according to section 3.12. 
 
3.21 Primer extension assay for mapping of transcription start site 
This method involves two parts, a primer extension step followed by 
GeneScan® Analysis.  
 The primer extension step was similar to the reverse transcription reaction for 
the preparation of cDNA (section 3.20) prior to PCR, except that reverse primers used 
here were specially labeled at the 5’ end with 6-carboxyfluorescein (6-FAM) 
fluorescent dye, instead of the usual primers. This gives rise to primer extension 
(cDNA) products which will be labeled with 6-FAM. 
 The size of these labeled cDNAs were then analyzed on an ABI Genetic 
Analyzer 3100 (Applied Biosystems) and the data was processed using the 
GeneScan® (version 3.5) software. For each analysis, an appropriate amount of 
sample (1 to 5 μl) was mixed with 0.5 μl marker in 10 μl of HI-DI formamide 
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(Applied Biosystems), which was vortexed briefly and transferred to a heat block at 
95oC for 2 min. The mixtures were then quick-chilled on ice before loading them into 
the analyzer. 
Presence of any dye-labeled nucleic acid fragment was identified as a distinct 
peak on the screen. Their respective sizes are determined by comparison with the 
known fragment lengths of the standard markers which were run alongside. Nucleic 
acid samples tagged with 6-FAM dye were detected as blue peaks. GeneScan-350 
(Applied Biosystems) which was labeled with the ROX dye, was used as the standard 
DNA marker and were detected as red peaks.     
  
3.22 Cloning of hmuY’ and hmuY for expression 
The entire sequence of hmuY’ and hmuY was amplified from the genomic 
DNA of P. gingivalis W50 using primer pairs hmuY’_BamHI_Fwd/hmuY_XhoI_Rev 
and hmuY_BamHI_Fwd/hmuY_XhoI_Rev respectively (Table 3.3). BamHI was 
engineered at the 5’ end of forward primers and XhoI was engineered at the 5’ end of 
the reverse primers to facilitate directional cloning into the pGEX-4T-1 vectors. PCR 
amplifications (see section 3.12) were carried out Pfu DNA Polymerase to ensure 
high fidelity. PCR products were then analyzed by agarose gel electrophoresis. 
PCR products were then finally cloned into pGEX-4T-1 via restriction sites 
BamHI and XhoI.  
 
3.23 Ligation of DNA 
Ligation was carried out using T4 DNA ligase (Promega).  The ligation 
mixture consisted of plasmid vector, insert DNA, 1X T4 DNA ligase buffer and 3 
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units of T4 DNA ligase, in a final volume of 10 μl. Reaction was incubated at 4°C 
overnight.  
 
3.24 Electroporation of E. coli  
3.24.1       Preparation of Electro-competent E. coli 
2 ml of overnight E. coli culture was transferred to a 1 L flask containing 200 
ml of LB broth and the culture was incubated at 37oC with shaking at 250 rpm for 2-3 
h until OD600 reached 0.5-0.7. The culture was then cooled in an ice-water bath for 30 
min and the cells were harvested by centrifugation at 4,000 ×g for 15 min. Cell pellets 
were washed sequentially with 200 ml, 100ml and 10 ml of 10% ice-cold sterile 
glycerol. After the washing, the cell pellets were resuspended in 200 µl of 10% ice-
cold sterile glycerol. The cell suspension was then stored in aliquots of 40 µl at -80oC 
until use. 
 
3.24.2      Electroporation of E. coli 
The electroporation was carried out using a Gene Pulser (Bio-Rad). An aliquot 
(40 µl) of frozen competent cells was allowed to thaw on ice and mixed with 3-5 µl of 
ligation mixture or 1 µl of intact plasmids. The cells were transferred into an ice-cold 
electroporation cuvette (Bio-Rad) and electroporation was performed with the Gene 
Pulser at 1.8 kV (for 0.1 cm cuvettes) or 2.5 kV (for 0.2 cm cuvettes), capacitance 25 
µF and resistance 200 Ω. Cells were immediately recovered in 1 ml of SOC medium 
(Appendix I) and incubated at 37oC for 1 h with shaking at 220 rpm. 
 
3.25 DNA sequencing 
DNA sequencing was performed commercially by Research Biolabs using the 
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ABI PRISMTM BigDye® Terminator Cycle Sequencing kit (Applied Biosystems) 
which is based on the dideoxy chain termination method of Sanger et al. (1977). 
Primers used for sequencing are described in Table 3.3.  
 
3.26 Expression of HmuY’ and HmuY recombinant proteins 
E. coli BL21(DE3) was transformed with pGEX-hmuY’ and  pGEX-hmuY 
(Table 3.2) separately and were used for expression of recombinant HmuY’ and 
HmuY respectively. Optimization of some of the parameters for expression was 
performed with the assistance of Honors student, Ms Lim Kah Jing, under my 
guidance and supervision.  
For each clone, a starter culture was obtained by inoculating a single colony 
into 5 ml of selective LB broth and incubating at 37oC with shaking at 220 rpm for 16 
h. For small scale optimization, 0.5 ml of starter culture was inoculated into 5 ml of 
fresh selective LB broth and growth allowed at 37oC, with shaking at 220 rpm and 
OD600 was monitored. Induction was performed at various OD600, e.g. 0.5, 0.8 and 1.6. 
Induction of fusion protein was achieved with addition of IPTG (Appendix I) at 
concentrations of 0.5 mM or 1 mM, and culture was further incubated at 25oC or 37oC, 
for 15 min to 16 h.  Samples were taken at intervals and analyzed on SDS-PAGE to 
determine the optimal expression conditions. 
 
3.27 Purification of HmuY’ and HmuY recombinant proteins 
After determination of the optimal conditions for expression, the culture 
volume was scaled up twenty folds to 100 ml and purification of GST fusion proteins 
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3.27.1        Preparation of bacterial sonicate 
Cultures grown under optimal conditions for expression were harvested by 
centrifuging at 7500 x g for 10 min at 4oC. Cells were then washed once with 1X PBS 
and resuspended in 50 μl 1X PBS per ml culture. 0.1 volume of lysozyme solution 
(Appendix I) was added and the mixture was incubated on ice for 30 min to aid lysis. 
Cells were then sonicated on ice using a 1/8 microtip probe (MSE Soniprep, Sanyo) at 
an amplitude of 14-16 μm for 25-30 cycles of 15 s pulses and 20 s pauses. Cell debris 
and unbroken cells were removed by centrifugation at 10,000 x g for 30 min at 4oC 
and supernatant transferred to a fresh tube. Supernatant may be further clarified by 
passing through a 0.45 μm filter. 
 
3.27.2       Purification of GST-fusion proteins with Glutathione Sepharose 
4B  
 Glutathione 4B beads were prepared to a 50% slurry following procedures in 
the GST Gene Fusion System Handbook (Amersham Biosciences).  
The batch purification protocol was carried out. Briefly, 1 ml of the 50% 
slurry of Glutathione Sepharose 4B was added to the 5 ml bacterial sonicate prepared 
above and mixed gently with end-on-end rotation at 4°C for 2 h to allow binding. 
Beads were sedimented by centrifuging at 500 x g for 5 min at 4°C and washed 3 
times with 10 ml of ice-cold 1X PBS.   
Protein was then eluted from the beads with 500 μl of Elution Buffer 
(Appendix I). The buffer was allowed to incubate with the beads at 4°C for 30 min 
with gentle agitation. This was repeated twice more for a total of three elutions. 
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Eluted protein in the supernatant was then collected after sedimentation of the beads 
at 500 x g for 5 min at 4°C.  
5 μl of purified protein fractions were analyzed on SDS-PAGE and the 
remaining proteins stored at -80°C.  
    
3.27.3      Concentrating proteins 
For proteins with a lower yield, purified fractions were pooled and proteins 
concentrated using the Amicon Ultra-4 (Millipore), with a molecular weight cut-off of 
5 kDa. 
  
3.27.4 Removal of GST tag by thrombin cleavage  
Presence of a thrombin cleavage site in pGEX-4T-1 allows for removal of the 
GST tag during purification. Thrombin cleavage was performed on GST fusion 
protein bound to Glutathione Sepharose 4B beads.  
This was performed following procedures in the GST Gene Fusion System 
Handbook (Amersham Biosciences). 1 unit thrombin (Amersham Biosciences) was 
used per 1 μg protein present.  
 
3.28 Quantification of proteins 
Concentrations of protein samples were determined using the Bio-Rad Protein 
Assay, which is based on the method of Bradford (Bradford, 1976). This assay is a 
dye-binding assay where a differential colour change of the dye corresponds to 
amount of proteins bound.  
The microassay for microtitre plates was performed. Five dilutions of BSA 
within the range of 8 to 80 μg/ml were prepared as standards. 160 μl of protein 
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standards or samples were pipetted into ٛ eparate wells of a flat-bottomed, transparent 
96-well microtitre plate (Nunc). 40 μl of Protein Dye Reagent Concentrate (Bio-Rad) 
was added and mixed thoroughly in each well. Reaction was then allowed to incubate 
for 5 min at room temperature before absorbance readings were taken with the 
Sunrise (Tecan) microplate reader at 595 nm. All standards and samples were done in 
triplicates (results not shown). 
  
3.29 Hemin-binding assay 
The method of detecting the hemin-binding properties of proteins was 
performed using the lithium dodecyl sulphate (LDS) polyacrylamide gel 
electrophoresis (PAGE) and staining with tretramethylbenzidine (TMBZ), following 
Stugard et al.  (1989) with slight modifications as described below.   
 
3.29.1      Preparation of proteins for hemin-binding 
 500 ng of purified recombinant proteins were incubated with 20 μg/ml hemin 
at 37oC for 30 min to allow binding of hemin. Negative controls were performed by 
incubating purified GST with hemin and incubating recombinant proteins without 
hemin at 37oC for 30 min.  
 
3.29.2     Lithium dodecyl sulphate-polyacrylamide gel electrophoresis 
(LDS-PAGE) 
LDS-PAGE gels were cast with resolving gel containing 0.1% LDS and 12% 
acrylamide in 0.375M Tris (pH 8.8) while stacking gel consists of 0.1% LDS and 4% 
acrylamide in 0.125M Tris (pH 6.8). The buffer for electrophoresis contains Tris, 
glycine and 0.1% LDS. Detailed composition of the gels and buffers are listed in 
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Appendix I. Gels were cast in duplicate for each sample. One will be used for 
Coomassie blue staining and the other for TMBZ staining. 
After hemin-binding, samples were mixed with 5X LDS Loading Buffer 
(Appendix I). This loading buffer does not contain reducing agents so as to preserve 
the association of the proteins with the hemin. Samples were split and loaded into 
duplicate gels without heating. The Protein Molecular weight marker (Fermentas) was 
heated at 95oC for 5 min and run alongside the samples. Samples were 
electrophoresed at 220V at 4oC in the dark for 1 h.  
 
3.29.3 Tetramethylbenzidine (TMBZ) staining 
Gels were first fixed in ice-cold 6:3:1 sodium acetate (Appendix I)-methanol-
ddH2O in the dark at 4oC for 1 h, with gentle agitation. TMBZ solution (Appendix I) 
was prepared fresh for each usage at a concentration of 6.3 mM in 20 ml of absolute 
methanol. This TMBZ solution was then added to 70 ml of ice-cold sodium acetate 
and 10 ml ddH2O. The gel was stained in this solution for 35 min in the dark in a 
shaking ice-water bath. Hydrogen peroxide (H2O2) was then added into the solution at 
a final concentration of 30 mM and gel was allowed to incubate for 30 min or until 
bands appear. Gels were washed immediately in 8:2 sodium acetate-isopropanol to 
stop the reaction and dried immediately. 
 
3.30 Construction of plasmid for insertion inactivation of hmuY’ 
hmuY’ gene was obtained from P. gingivalis genomic DNA by PCR using Pfu 
Polymerase with primers hmuY’_Fwd/hmuY’_Rev (Table 3.3), and ligated into 
pGEM-T vector after addition of 3’ A-overhangs (see section 3.12.1).  
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ermF cassette was obtained pVA2198 by PCR using primers 
ermF_ClaI_Fwd/ermF_ClaI_Rev (Table 3.3) and cloned into the ClaI site of hmuY’ in 
pGEMT-hmuY’. Resultant plasmid obtained is pGEMT-hmuY’-ermF. 
Ligation and transformation of plasmids into E. coli was done following 
sections 3.23 and 3.24.  
Plasmid pGEMT-hmuY’-ermF was then extracted from E. coli following 
plasmid extraction protocol in section 3.3.1. The plasmid was then linearized by 
digestion with BglI and NdeI before transformation into P. gingivalis as follows.  
  
3.31 Electroporation of P. gingivalis 
Electroporation of P. gingivalis was performed following Fletcher et al. (1995) 
as described below, with slight modifications. 
  
3.31.1       Preparation of Electro-competent P. gingivalis 
1 ml of an actively growing culture of P. gingivalis W50 was inoculated into 
10 ml of standard Pg broth (section 3.2.2). 3 ml of this fresh overnight culture was 
then used to inoculate 70 ml of standard Pg broth and incubated for another 4-6 h or 
until OD600 was 0.3-0.4. Cells were chilled in an ice-water bath for 30 min and 
harvested by centrifugation at 4000 x g for 15 min at 4oC. Cells were then washed 
sequentially with 70 ml, 35 ml and 5 ml of ice-cold sterile EP buffer (Appendix I) 
gently, and finally resuspended in 500 μl of ice-cold EP buffer. Cells were prepared 
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3.31.2       Electroporation of P. gingivalis 
80 μl of electrocompetent P. gingivalis W50 was mixed with 1 μg of 
linearized pGEMT-hmuY’-ermF plasmid and transferred to an ice-cold sterile 0.1-cm 
electroporation cuvette (Bio-Rad).  Cells were electroporated with the Gene-Pulser 
(Bio-Rad) set at 1.8 kV, 25 µF and 200 Ω. After the pulse, cells were incubated on ice 
for 3 min. 1 ml of standard Pg broth was then added and the cells were transferred to a 
fresh 5 ml sterile culture tube (Falcon), which was left to incubate anaerobically at 
37oC for 16 h to allow recovery. 
Following the overnight incubation, cells were gently pelleted at 3500 x g for 
10 min, resuspended in a final volume of 100 μl standard Pg broth and all the cells 
were plated onto TSA 5 % sheep blood agar supplemented with 5 µg/ml hemin, 1 
mg/ml L-cysteine, 1 µg/ml menadione and 5 µg/ml erythromycin. Plates were 
incubated anaerobically at 37oC for 5-7 days.  
 
3.32 Immunogold localization of HmuY’ by Transmission Electron 
Microscopy (TEM) 
3.32.1      Preparation of specimens (Embedding and Thin Sectioning) 
Mid-log phase cultures of P. gingivalis W50 (grown in standard Pg broth) was 
fixed by adding an equal volume of Double-strength Primary Fixative (Appendix I) to 
the culture. This was incubated at room temperature for 20 min. Cells were then 
pelleted by centrifugation at 5000 x g for 10 min. The supernatant was discarded and 
pellet was resuspended in 1 to 2 ml of fresh Primary Fixative, which was then left to 
incubate at 4oC for 30 min. Cells were washed 3 times in 1X PBS for 5 min each and 
dehydrated in an ascending graded ethanol series at room temperature (25% ethanol 
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for 5 min; 50% ethanol for 10 min; 75% ethanol for 20 min; 95% ethanol for 20 min; 
absolute ethanol for 20 min each for 3 changes).  
LR white was used to embed the samples and it was infiltrated into the 
samples by passing samples, at room temperature, through: 
i.) 1 part ethanol with 1 part LR white for 30 min  
ii.) 1 part ethanol with 3 parts LR white for 30 min  
iii.) Pure LR white for 1 h 
iv.) Pure LR white for 1 h 
v.) Pure LR white overnight 
Continue with infiltration of pure LR white the next day for 3 changes for 1 h each. 
Samples are finally transferred into a gelatine capsule filled with LR white and LR 
white will be allowed to polymerize at 50oC for 48 h, thereby embedding the sample 
after polymerization. As oxygen retards polymerization, care is taken to avoid 
exposure of LR white to oxygen throughout this incubation step. 
Thin sections were then prepared using a Leica Ultra-Cut 10 ultramicrotome 
and transferred onto nickel grids.  
 
3.32.2  Immunogold labeling 
Nickel grids containing thin sections of P. gingivalis W50 were washed in 1X 
PBS, followed by 0.05 M glycine in 1X PBS to inactivate residual aldehyde. Grids 
were washed again in 1X PBS and then incubated in blocking buffer (5% BSA in 1X 
PBS) for 30 min to block any non-specific protein binding sites. Washing was done 
subsequently in 0.1% BSA in 1X PBS.  
  Primary antibody (HmuY peptide-specific anti-serum) was diluted 1:200 in 
1X PBS with 0.1% BSA and incubated with the grids for 1 h at room temperature. 
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Pre-immune anti-serum was used as the negative control primary antibody. Grids 
were then washed 6 times for 5 min each to remove non-specific primary antibodies. 
Goat anti-rabbit IgG, conjugated with 10nm gold particles, (Sigma) was used as the 
secondary antibody and diluted 1:200 in 1X PBS with 0.1% BSA. Grids were 
incubated with the secondary antibody for 1 h at room temperature. Grids were then 
washed 6 times with 0.1 % BSA in 1X PBS to remove excess secondary antibodies. 
The antibodies were then fixed with 2% glutaraldehyde in 1X PBS for 5 min and 
washed with 1X PBS, followed by ddH2O.  
 
3.32.3  Staining of nickel grids  
Each grid was dried and placed on top of a drop of uranyl acetate (Appendix I) 
for 5 min. After which, the grid was flushed with ddH2O and dried before placing it 
on top of a drop of lead citrate solution (Appendix I) for 5 min. The grid was again 
flushed with ddH2O and dried. 
 
3.32.4   Viewing of grids  
Viewing of specimens was done with a Philips EM208S transmission electron 










Chapter 4 Results 
Chapter 4 
Results 
4.1 Western blot analysis of P. gingivalis W50 using HmuY peptide-specific 
antiserum 
To determine expression of HmuY in vivo in P. gingivalis, antibodies were 
raised against HmuY using a synthetic 14-mer peptide with the sequence 
YEMGPDGHQMEYEE. The peptide’s sequences correspond to amino acids 53 to 65 
of HmuY (Genbank Accession no. AAF07986).  
Specificity of the HmuY peptide-specific antiserum was confirmed 
commercially by the company using ELISA and further confirmed by dot blot 
analysis in our laboratory using the purified peptide as antigen (results not shown). 
Negative controls with pre-immune serum and BSA did not give any reactions as 
expected (results not shown).  
Western blot analysis was carried out on P. gingivalis W50 whole cell lysate 
using the HmuY peptide-specific antiserum. Fig. 4.1A shows the SDS-PAGE gel of 
the whole cell lysate stained in Coomassie blue. The predicted size of HmuY, based 
on its deduced amino acid sequence, was 16 kDa (Bjellqvist et al., 1994; Bjellqvist et 
al., 1993). However, detection with the HmuY peptide-specific antiserum gave only a 
single band of approximately 24 kDa (Fig. 4.1B). No band corresponding to the 
expected size of 16 kDa of HmuY was observed.  
 
4.2 Mass spectrometry analysis  
To confirm the identity of the 24 kDa protein detected, the protein band was 
excised from the gel and subjected to matrix-assisted laser desorption ionization 
tandem mass spectrometry (MALDI-MS/MS) analysis with the technical assistance of 
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staff at the Proteins and Proteomics Centre, Department of Biological Sciences, NUS. 
Fig. 4.2 shows the mass spectrum obtained from the first round of mass spectrometry 
(MALDI-MS).  
The peptide mass fingerprint data from the spectrum was searched against the 
protein database using the search engine, Mascot (Perkins et al., 1999). Search results 
revealed the protein to have a highly significant match to HmuY with a high score of 
449 and E-value of 4.1e-39 (Appendix II). Table 4.1 lists the peak values (Observed) 
from the mass spectrum that matched the predicted peptide masses (Mr (expt) and Mr 
(calc)) from the database, together with their corresponding peptide sequences. These 
peak values are also indicated in red in Fig. 4.2.  
 In tandem mass spectrometry (MS/MS), ions corresponding to peptide 
fragments were selected automatically after the first round of mass spectrometry and 
allowed to undergo further fragmentation. Mass spectrum of these peptides will be 
obtained that allows the determination of the amino acid sequence of these peptides. 
Instead of reading the mass spectra manually, an automated search of the database 
was done with these MS/MS results.  The outcome of the search was reflected as the 
ions score shown in Table 4.1. A score of 65 indicates 95 % confidence of a positive 
match to the peptide sequence in the database (Perkins et al., 1999).  
Three peptide fragments were selected and two of the peptides had high ions 
score of 141 and 160 respectively (Table 4.1). Thus, this confirms the presence of 
these peptide sequences in the 24 kDa protein, thereby indicating that the 24 kDa 
protein harbors the HmuY amino acid sequences.  
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Fig. 4.1. Detection of HmuY protein in vivo in P. gingivalis W50. (A) SDS-PAGE 
of P. gingivalis W50 whole cell lysate stained in Coomassie blue. (B) Western blot 



















































Fig. 4.2. MALDI spectrum of the 24 kDa protein band. Peptide masses which 
correspond to HmuY peptide sequences are in bold red (See also Table 4.1). Peptide 



















































































































































































































































































































































































































































































































































































































Table 4.1. List of peptide masses and their matching sequences from HmuY 
 
Observed Mr (expt) Mr (calc) Ions 
Amino 
acid 
positions Peptide Sequence 
823.50   822.49   822.49  ---  104 -109 RVFFVR 
1388.74   1387.74   1387.74  ---  131-142 GVITFTYTYPVK 
1456.71   1455.70   1455.69  ---  118-129 VQFTDYQDAELK 
1584.79   1583.79   1583.78  46  118-129 VQFTDYQDAELKK 
2269.05   2268.05   2268.06  160  28-48 TEMDQATTVPTDGYTVDVLGR 
2285.11 2284.10 2284.05 ---         28-48 TEMDQATTVPTDGYTVDVLGR + 
Oxidation (M) 
2379.09   2378.08   2378.11  141  78-100 NAQGFASGGWLEFSHGPAGPTYK 
2761.13   2760.13   2760.17  ---  53-76 YEMGPDGHQMEYEEQGFSEVITGK 






















Chapter 4 Results 
4.3 Sequence analysis revealed novel open-reading frame, hmuY’ 
Since the protein found to be expressed in vivo was larger than expected, we 
explored the possibility of an alternative start site upstream of the hmuY gene that will 
give rise to a protein that is equivalent to 24 kDa in size. Sequence analysis of the 
genome sequence of P. gingivalis W83 (Accession no. NC002950) in the National 
Center for Biotechnology Information (NCBI) database led to the discovery of an 
ATG translational start codon 222 bp upstream of the previously suggested hmuY 
translational start codon (Fig. 4.3). This alternative translational start codon (ATG) 
was in-frame with the stop codon (TAA) of hmuY, thus giving rise to a new open-
reading frame (ORF). This new ORF was designated as hmuY’.  
hmuY’ was found to be 651 bp in length and predicted to code for a protein of 
217 amino acids, with an estimated molecular weight of 23.8 kDa (Bjellqvist et al., 
1993; Bjellqvist et al., 1994). This correlates well with the molecular weight of the 
protein band detected by Western blot analysis using HmuY peptide-specific 
antiserum.  
Further analysis of the mass spectrum of the 24 kDa protein and the deduced 
HmuY’ amino acid sequence was carried out. Peptide masses of HmuY’, after 
digestion by trypsin, were predicted using the PeptideMass prediction software from 
ExPASy Proteomics Tools at http://kr.expasy.org/tools/peptide-mass.html (Wilkins et 
al., 1997) (Appendix II). Comparison of the mass spectrum and predicted peptide 
masses revealed peaks that matched very well to predicted peptide masses from the 
HmuY’ protein sequence. These peaks are indicated in blue in Fig. 4.2. Peptide 
sequences that correspond to the matching peptide masses (blue peaks) are 
highlighted in grey in Fig. 4.3.  
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A putative Shine-Dalgarno (SD) sequence (AAGG) was also found upstream 
of this newly identified ATG (Fig. 4.3). In addition, an inverted repeat 
sequence“GCAGGCCctcatcGGCCTGC” was identified 32 nucleotides downstream 
from the stop codon (Fig. 4.3), this is proposed to be a rho-independent transcription 
terminator using the transcription terminator prediction programme, TransTerm, 
available at http://transterm.cbcb.umd.edu/ (Ermolaeva et al., 2000). This programme 
is also accessible from The Institute for Genomic Research (TIGR) website at 
http://www.tigr.org/software/genefinding.shtml.  
 
4.4 HmuY’ is a putative lipoprotein 
Analyses of the amino acid sequence of HmuY’ revealed a characteristic 
prokaryotic signal peptide sequence, with a net positive charge at the N-terminus (a 
Met followed by two Lys residues), a hydrophobic stretch in the middle and a 
peptidase cleavage site at the end. Further, a consensus sequence of a prokaryotic 
lipoprotein attachment site (Prosite accession PDOC00013) at amino acids 11Ala-Leu-
Pro-Leu-Ile-Val-Ser-Leu-Thr-Ser-Cys21 was identified on the N-terminus region of 
the protein (Klein et al., 1988) (Fig. 4.3). Using a software (LipoP; 
www.cbs.dtu.dk/services/LipoP/, Juncker et al., 2003) for the prediction of 
lipoproteins and their signal peptides, a lipoprotein signal peptidase II cleavage site 
was found to be between 20Ser-Cys21. A glycine (Gly) residue was found at the +2 
position after this cleavage site and is predicted to target the lipoprotein to the outer 
















           SD 
-60      GAACATCTCAACTTTGCAGCCGGATGAAACCTATTAAAAGTAAGGTCAGATAATTATGAA 
         hmuY’       
1        ATGAAAAAAATCATTTTCTCCGCACTCTGTGCATTGCCATTGATTGTGTCTCTAACTTCT 
1         M  K  K  I  I  F  S  A  L  C  A  L  P  L  I  V  S  L  T  S   
61       TGTGGGAAGAAGAAAGACGAGCCGAACCAACCCTCCACACCCGAAGCAGTAACCAAAACC 
21        C  G  K  K  K  D  E  P  N  Q  P  S  T  P  E  A  V  T  K  T   
      ClaI 
121      GTAACTATCGATGCTTCGAAATACGAAACGTGGCAGTATTTCTCTTTTTCCAAAGGTGAA 
41        V  T  I  D  A  S  K  Y  E  T  W  Q  Y  F  S  F  S  K  G  E   
                                                   hmuY 
181      GTCGTAAATGTTACCGACTATAAGAACGATTTGAACTGGGACATGGCTCTTCACCGCTAT 
61        V  V  N  V  T  D  Y  K  N  D  L  N  W  D  M  A  L  H  R  Y         
241      GACGTTCGTCTCAATTGTGGCGAAAGTGGTAAGGGAAAAGGTGGTGCCGTATTCTCCGGC 
81        D  V  R  L  N  C  G  E  S  G  K  G  K  G  G  A  V  F  S  G   
301      AAGACAGAAATGGATCAGGCTACTACCGTTCCGACAGACGGATATACTGTAGATGTTCTC 
101       K  T  E  M  D  Q  A  T  T  V  P  T  D  G  Y  T  V  D  V  L   
361      GGCCGTATTACAGTCAAGTACGAAATGGGACCTGATGGTCATCAGATGGAATATGAAGAA 
121       G  R  I  T  V  K  Y  E  M  G  P  D  G  H  Q  M  E  Y  E  E   
421      CAGGGCTTCAGCGAAGTGATTACCGGCAAGAAGAACGCACAGGGATTTGCTTCAGGTGGT  
141       Q  G  F  S  E  V  I  T  G  K  K  N  A  Q  G  F  A  S  G  G  
      EcoRI  
481      TGGCTGGAATTCTCTCACGGTCCTGCCGGTCCCACTTACAAGCTGAGCAAAAGAGTCTTC 
161       W  L  E  F  S  H  G  P  A  G  P  T  Y  K  L  S  K  R  V  F   
541      TTCGTTCGTGGTGCTGATGGTAATATTGCCAAAGTGCAGTTCACTGACTATCAGGATGCA 
181       F  V  R  G  A  D  G  N  I  A  K  V  Q  F  T  D  Y  Q  D  A   
             Stop 
601      GAACTCAAAAAAGGAGTCATCACTTTCACTTATACATACCCCGTTAAATAAGTTAAGAGG  
201       E  L  K  K  G  V  I  T  F  T  Y  T  Y  P  V  K  *      
661       GAAATATGAAAAGTGTAGTAACAAgcaggccCTCATCggcctgcTTTTCTTTAGTATAA 
 
Fig. 4.3. Complete nucleotide sequence (numbered on left in italics) of P. 
gingivalis hmuY’ (GenBank Accession No. EF055489) and its deduced amino acid 
sequence (numbered on left in bold). Start of hmuY gene and its amino acid 
sequence (Genbank Accession No. AF200358) is also indicated. Stop codon (common 
to both genes) is indicated with an asterisk. Highlighted in grey are peptide sequences 
with predicted masses that match the peaks on the mass spectrum (indicated in blue in 
Fig. 4.2). Putative lipoprotein attachment site is in bold and underlined. Shine-
Dalgarno site of hmuY’ (SD) is underlined. Proposed rho-independent terminator loop 
sequences are indicated as small letters in pink italics. Two restriction sites present in 








Chapter 4 Results 
4.5 Confirmation of hmuY’ sequence in strain W50 
To confirm that the sequence of hmuY’ and its flanking regions in strain W50 
was similar to that of strain W83 in the database, sequencing of P. gingivalis W50 
genomic DNA was carried out. Results confirm that sequences of hmuY’ and those 
156 bp upstream to 139 bp downstream of the gene were 100% identical to that of 
strain W83 (results not shown). 
 
4.5.1 Confirmation of genomic locations of hmuY’ and hmuY 
To determine if hmuY’ and hmuY were present in more than one copy and to 
confirm the genomic location of these genes in strain W50, Southern blot analysis was 
carried out. Genomic DNA from strain W50 was digested with BamHI and hybridized 
separately with one probe specific for the 5’ end of hmuY’ and the other for hmuY. A 
single band of ~2400 bp was obtained for both probes (Fig. 4.4). The band 
corresponds to the expected size of 2333 bp for the fragment containing hmuY, which 
was predicted from restriction analysis of strain W83 in the NCBI database. These 
results show that both hmuY’ and hmuY are present on the same segment of the 
genome and both genes occur as a single copy. 
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Fig. 4.4. Southern blot analyses of BamHI-digested P. gingivalis W50 genomic 
DNA hybridized with probes specific for hmuY’ and hmuY. Lane MW: DNA 
molecular weight marker II, DIG-labeled (Roche); Lane hmuY’: Hybridized with 













Chapter 4 Results 
4.6 Transcript analyses of hmuY’ and hmuY 
Since hmuY’ and hmuY overlap on the same segment of the genome but only 
HmuY’ was detected but not HmuY, we sought to determine the transcription 
organization of these genes. Transcriptional start site mapping and Northern blot 
analysis were carried out. 
 
4.6.1. Northern blot analyses of hmuY’ and hmuY 
All total RNA extracted from P. gingivalis W50 were DNase-treated prior to 
Northern analyses. Purity of these DNase-treated total RNA samples was confirmed 
by spectrophotometric analysis of OD260/OD280 ratio which was found to be greater 
than 1.9. The RNA samples were also separated and visualized by agarose gel 
electrophoresis to assess its integrity prior to transfer onto the nitrocellulose 
membranes. The RNA was found to be of good quality as indicated by the distinct 
23S and 16S bands (Fig. 4.5A).  
To determine whether there were alternative transcripts of hmuY’ and hmuY 
and the length of these transcripts, Northern blot analysis was carried out with one 
probe specific for the 5’ end of hmuY’ and another for the internal region of hmuY, on 
P. gingivalis W50 total RNA.  Results showed that a single dark band of ~750bp was 
obtained for both of the probes (Fig. 4.5B). These results suggest that hmuY’ and 
hmuY are present on the same transcript. Some light bands were present above the 750 
bp band. These bands were merely artifacts of the abundant 23S and 16S ribosomal 
RNAs as positive reactions will show up as darkened bands, a result of fluorescence 
on the X-ray film. No other bands that may correspond to alternative transcripts of 
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4.6.2. Transcript start site mapping of hmuY’ and hmuY 
Preliminary mapping of the transcriptional start sites of both hmuY’ and hmuY 
were attempted using a novel non-radioactive method of primer extension assay 
(Leong, 2004). This method makes use of reverse primers, which were labeled at the 
5’ end with fluorescent dye (6-FAM) instead of radioactive isotopes and targeting 
either nucleotides 25-43 of hmuY’ or nucleotides 46-64 of hmuY, using the primers 
hmuY’_Rev_6FAM and hmuY_Rev_6FAM (Table 3.3 and Fig 4.3) respectively. 
Reverse transcription using these primers would proceed towards the 5’ end of the 
mRNA which will eventually stop at the nucleotide corresponding to the 
transcriptional start site. Accurate determination of the size of these primer extension 
(cDNA) products were then carried out using the ABI Genetic Analyzer and 
GeneMapper® (ver3.5) analysis software and the transcriptional start site can be 
mapped with the size information obtained. Results from the GeneMapper® analysis 
showing the size of these cDNA products are presented in Fig. 4.6. 6-FAM-labeled 
products are displayed as blue peaks and the ROX-labeled standards are displayed as 
red peaks. 
A 70 bp and 313 bp product was obtained with primer hmuY’_Rev_6FAM 
(Fig. 4.6A) and with primer hmuY_Rev_6FAM (Fig. 4.6C) respectively. With this 
size information obtained, the transcript start site of hmuY’ was mapped to the 
nucleotide 70 bp upstream of nucleotide 43 (corresponding to the 5’ end of 
hmuY’_Rev_6FAM primer) of hmuY’ and that of hmuY was mapped to the nucleotide 
313 bp upstream of nucleotide 64 (corresponding to the 5’ end of hmuY_Rev_6FAM 
primer) of hmuY (Fig. 4.7). 
Analysis of the DNA sequence found that the transcriptional start site of both 
hmuY’ and hmuY were mapped to the same nucleotide, which is an adenosine residue 
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(indicated with a +1 in Fig. 4.7). This adenosine nucleotide is located 27 bp and 239 
bp upstream from the ATG translational start site of hmuY’ and hmuY respectively 
(Fig. 4.7).  
To confirm accuracy of the size determination and mapping, RT-PCR was 
carried out using these reverse primers (hmuY’_Rev_6FAM and hmuY_Rev_6FAM) 
and a forward primer (Pm1_Fwd) designed with this transcriptional start site at the 5’ 
end. Size of these RT-PCR products were then determined using the same method and 
results were compared with the known sizes of these RT-PCR products. Fig. 4.6B and 
4.6D show the sizes of the RT-PCR products determined from GeneMapper® analysis 
using primer pairs Pm1_Fwd/hmuY’_Rev_6FAM and Pm1_Fwd/hmuY_Rev_6FAM 
respectively. These results were found to correlate well with the expected sizes of 70 
bp and 313 bp respectively. As a control, another forward primer (Pm2_Fwd), 
designed upstream of the transcript start site did not give any products with RT-PCR 
(data not shown). There were also no products for the no-template controls (NTC) and 
controls without reverse transcriptase (data not shown), thereby ruling out any 
genomic DNA contamination. 
  Further, it was found that the predicted transcript size of 736 bp, from this 
mapped transcript start site to the proposed rho-independent terminator, was in 
agreement with the transcript size of ~750 bp obtained from the Northern blot 
analysis. These results, together with the Northern blot analyses, suggest that hmuY’ 
and hmuY were transcribed on the same transcript, with the size of ~750 bp. There 
were no detectable alternative transcripts of hmuY alone.  
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Fig. 4.5. Agarose gel electrophoresis of total RNA and Northern blot analysis of P. 
gingivalis W50.  (A) Total RNA samples of P. gingivalis W50 (with glyoxal/DMSO 
in loading buffer as denaturant) were analyzed on a 1% agarose gel for quality of 
RNA. Lane MW: RNA ladder, high range (Fermentas); Lane 1: RNA sample used for 
hybridization with hmuY’ probe; Lane 2: RNA sample used for hybridization with 
hmuY probe. (B) Northern blot analysis of total RNA using probes specific to hmuY’  
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C
D
Fig.  4.6. GeneMapper® (ver 3.5) analyses of primer extension and RT-PCR 
products. 6-FAM-labeled primer extension (cDNA) and RT-PCR products are 
indicated by blue peaks and ROX-labeled fragments of the GeneScan® marker 
(GS350) are indicated by red peaks. (A) Primer extension products and (B) RT-PCR 
products obtained with primers specific for hmuY’. (C) Primer extension products and 
(D) RT-PCR products obtained with primers specific for hmuY. Sizes of peaks-of-















-360     TCTCTTGAGTTCATAGGCTGCTGCCGCAAGAAGTATGTTCACGGTGTCCACTCTCATCCC 
-300     AGCGATAACCTTCTCTTTTTCAAAGGCCTCATTAGATGATTTTCCTTGTCGTGCCATAGC 
-240     TTTGTGTCATTGATCATACCATAAACACACGGAATAATCGGCTGATACACAAATAATAAA  
-180     TGAATAAAAGCACCTATGTATCGAGGGCTTTTTCATGTGCAATTCCAGTATTCCCAATAC 
            P5’ 
-120     CACTTATTTAGTATAAATCCGACATTAAATACCTACAAATTGGGATTGCTCGTTTTTTGT
          P3’   P3’’   +1     SD 
-60      GAACATCTCAACTTTGCAGCCGGATGAAACCTATTAAAAGTAAGGTCAGATAATTATGAA 
Pm1_Fwd Pm2_Fwd  
         hmuY’                hmuY’_Rev_6FAM 
1        ATGAAAAAAATCATTTTCTCCGCACTCTGTGCATTGCCATTGATTGTGTCTCTAACTTCT 
 
61       TGTGGGAAGAAGAAAGACGAGCCGAACCAACCCTCCACACCCGAAGCAGTAACCAAAACC
     
121      GTAACTATCGATGCTTCGAAATACGAAACGTGGCAGTATTTCTCTTTTTCCAAAGGTGAA 
                                                   hmuY 
181      GTCGTAAATGTTACCGACTATAAGAACGATTTGAACTGGGACATGGCTCTTCACCGCTAT 
              hmuY_Rev_6FAM       
241      GACGTTCGTCTCAATTGTGGCGAAAGTGGTAAGGGAAAAGGTGGTGCCGTATTCTCCGGC 
301      AAGACAGAAATGGATCAGGCTACTACCGTTCCGACAGACGGATATACTGTAGATGTTCTC   
361      GGCCGTATTACAGTCAAGTACGAAATGGGACCTGATGGTCATCAGATGGAATATGAAGAA 
 
 
Fig. 4.7. Mapping of the transcription start site and analysis of the promoter 
region of hmuY’and hmuY. The transcript start site of both hmuY’and hmuY is 
mapped to the same nucleotide which is indicated with a +1 and highlighted in green. 
Sequences of primers used for primer extension and RT-PCR are indicated and 
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4.7 Cloning and expression of hmuY’ and hmuY 
To investigate the possible functions of HmuY’ and HmuY, recombinant proteins 
were obtained from E. coli. 
 
4.7.1. PCR amplification 
The entire ORFs of hmuY’ and hmuY were both amplified from P. gingivalis 
W50 genomic DNA using forward and reverse primers containing BamHI and XhoI 
restriction sites, engineered respectively to the 5’ ends of the primers, so as to 
facilitate cloning of the inserts into the expression vector. PCR products with the size 
of 651 bp for hmuY’ and 429 bp for hmuY were obtained as expected (Fig. 4.8). 
 
4.7.2. Characterization of recombinant clones 
PCR fragments of hmuY’ and hmuY were cloned into the expression vector, 
pGEX-4T-1, via BamHI and XhoI. Resultant plasmids pGEX-hmuY’ and pGEX-hmuY 
were checked by PCR (results not shown) as well as restriction digests using BamHI 
and XhoI. Fig. 4.9 shows the fragments corresponding to expected sizes of linearised 
pGEX-4T-1, hmuY’ and hmuY. These results indicate presence of the correct inserts in 
the respective clones.  
To further confirm the identity of the clones and to check the joining 
sequences, DNA sequencing was performed using the pGEX-Fwd and pGEX-Rev 
sequencing primers (Table 3.1) (results not shown). This sequencing verified that the 
inserts had no mutations and were in the proper orientation with the correct junctions 
present such that the reading frame was maintained.  
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Fig. 4.8. Agarose gel analysis of PCR products of hmuY’and hmuY. Lane MW: 2-
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Fig. 4.9. Restriction digests of pGEX-hmuY’and pGEX-hmuY. Lane MW: 2-log 
DNA ladder (NEB), Lane 1: undigested pGEX-4T-1, Lane 2: linearised pGEX-4T-1, 
single-digested with SphI, Lane 3: pGEX-hmuY’digested with BamHI and XhoI, Lane 
4: undigested pGEX-hmuY’, Lane 5: pGEX-hmuY digested with BamHI and XhoI, 












Chapter 4 Results 
4.7.3. Expression of hmuY’ and hmuY 
Recombinant plasmids pGEX-hmuY’ and pGEX-hmuY were transformed into 
E. coli BL21(DE3) for expression.  E. coli BL21(DE3) was chosen for its protease-
deficient characteristics, thereby preventing degradation of the recombinant proteins. 
Optimization of the growth conditions for the optimal expression of hmuY’ and hmuY 
were carried out on a small scale prior to large-scale production of the fusion proteins. 
With the help of an Honours student, Ng Kah Jing, optimization of GST-
HmuY’ expression was carried out. Expression of GST-HmuY’ was found to be 
optimum at 4h post-induction, with 0.5 mM IPTG at 25 °C (Fig. 4.10).  
Expression of GST-HmuY was also optimized at various IPTG concentrations 
and temperatures of induction (results not shown). However, yield of soluble GST-
HmuY was always low. So induction was compared with different cell densities 
(OD600) and induction times, as shorter induction times at higher cell densities may 
reduce formation of inclusion bodies (GST Gene Fusion System Handbook, GE 
Healthcare). Expression of GST-HmuY was found to be optimum after induction at 







































Fig. 4.10. Optimization of expression of GST-HmuY’fusion protein. Lane MW: 
Protein molecular weight marker, unstained (Fermentas), Lane 1: uninduced E. coli 
harboring pGEX-HmuY’, Lanes 2-5: E. coli harboring pGEX-HmuY’, induced with 
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Fig. 4.11. Optimization of expression of GST-HmuY fusion protein. Lane MW: 
Protein molecular weight marker, unstained (Fermentas), Lanes 1-2: E. coli harboring 
pGEX-HmuY, induced with 0.5 mM IPTG at OD600 of 1.6 at 25 °C, for 15min and 30 
min respectively. Lanes 3-4: uninduced E. coli harboring pGEX-HmuY at OD600 of 
1.6 and 0.8 respectively. Lanes 5-6:  E. coli harboring pGEX-HmuY, induced with 0.5 
mM IPTG at OD600 of 0.8 at 25 °C, for 1h and 2h respectively. Lane 7: Elution 
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4.8 Purification of HmuY’ and HmuY 
Expression of hmuY’ and hmuY from the pGEX-4T-1 expression vector 
resulted in recombinant proteins with an N-terminal GST fusion tag. This GST tag 
provides an easy purification of the recombinant proteins by affinity chromatography 
using Glutathione Sepharose 4B beads. The expected size of the GST alone was 26 
kDa. Thus, when this GST tag was fused to the 24 kDa HmuY’, a protein of 
approximately 50 kDa will be expected for GST-HmuY’. Likewise for the 16 kDa 
HmuY, the fusion protein GST-HmuY will have an expected size of approximately 42 
kDa.   
SDS-PAGE analyses of the purified fusion proteins revealed a band of ~50 
kDa for the GST-HmuY’ protein and a band of ~42 kDa for the GST-HmuY protein 
as expected (Fig. 4.12A, lanes 1 and 2 respectively). The expected 26 kDa band of 
GST alone was also obtained (Fig. 4.12A, lane 3), indicating success of the 
expression and purification procedures. Other than the expected 50 kDa band, another 
band of ~26 kDa was also obtained for purified GST-HmuY’ protein. This band was 
likely to be GST (See also section 4.10). Several other faint protein bands were also 
observed for GST-HmuY, indicating contamination of GST-HmuY with some host 
proteins. This may be due to the low expression of HmuY, which has led to more non-
specific binding of other host proteins on the sepharose beads. However, GST-HmuY 
was present as the protein with highest abundance. 
 
4.9 Removal of GST tag from HmuY’ and HmuY fusion proteins 
To rule out effect of the GST on the possible function and activity of the 
proteins, the GST tag was removed using thrombin. Fig. 4.13 shows the HmuY’ and 
HmuY proteins after successful removal of the GST tag. An expected band of 24 kDa 
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was obtained for HmuY’ (Fig. 4.13, lane 1) while a 16 kDa band was obtained as 
expected for HmuY (Fig. 4.13, lane 2). Relatively pure proteins were obtained as 
indicated by the prominent band of the protein-of-interest with little background.  
 
4.10 Detection of HmuY’ and HmuY proteins 
To confirm presence of the recombinant proteins after purification and GST 
tag removal, Western blot analysis was carried out using the HmuY peptide-specific 
antiserum.  
Only the 50 kDa GST-HmuY’ was detected with the HmuY peptide-specific 
antiserum (Fig. 4.12B, lane 1). The 26 kDa band that was present in the Coomassie-
stained gel was not detected here, indicating that it was not the desired protein. 
Western blot analysis with anti-GST antibody was positive for this 26 kDa band 
(results not shown), indicating that it was indeed GST. GST-HmuY was also detected 
as expected (Fig. 4.12B, lane 2) as a 42 kDa band. Presence of other band in the 
Western blot analysis for GST-HmuY could be due to cross-reactivity with some E. 
coli proteins as purification of HmuY was not as optimum due to the lower expression 
of the protein. No band was detected for the negative control with GST alone (Fig. 
4.12B, lane 3) indicating specificity of the antiserum for the recombinant proteins and 
not GST. 
Western blot analysis of HmuY’ and HmuY proteins after removal of the GST 
tags showed bands of the expected sizes of 24 kDa and 16 kDa respectively (Fig. 
4.13B), confirming that the recombinant proteins were successfully obtained 
following GST tag removal.     
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Fig. 4.12. SDS-PAGE and Western blot analysis of purified recombinant GST-
fusion proteins. (A) SDS-PAGE of purified GST-fusion proteins stained in 
Coomassie blue. (B) Western blot analysis of GST-fusion proteins with HmuY 
peptide-specific antiserum. Lane MW: Protein molecular weight marker, unstained 































































Fig. 4.13. SDS-PAGE and Western blot analysis of purified recombinant proteins 
HmuY’ and HmuY, without GST tags. (A) SDS-PAGE gel of purified HmuY’ and 
HmuY after removal of GST tags, stained in Coomassie blue. (B) Western blot 
analysis of recombinant HmuY’ and HmuY proteins after removal of GST tags, using 
HmuY peptide-specific antiserum. For both (A) and (B), Lane MW: Protein 
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4.11 Hemin-binding assay using LDS-PAGE and TMBZ staining  
HmuY was found to possess similarities (Simpson et al., 2000) to segments of 
a hemin-binding protein described by (Kim et al., 1996) (Fig. 4.14). Thus it was 
proposed that HmuY’ and HmuY may possess similar hemin-binding properties as 
well. To confirm this, hemin-binding activity of HmuY’ and HmuY, was assayed by 
LDS-PAGE and TMBZ staining, which detects the peroxidase activity of the heme-
associated proteins. 
 
4.11.1. Hemin-binding assay of fusion proteins 
First, fusion proteins of HmuY’ and HmuY were assayed. Fig. 4.15A shows 
LDS-PAGE analysis of GST-HmuY’, GST-HmuY, as well as GST alone, after 
incubation with hemin and stained with Coomassie-blue to indicate presence of the 
proteins in almost similar quantities. Fig. 4.15B shows a duplicate of the LDS-PAGE 
gel in Fig. 4.15A stained with TMBZ. A darkened band corresponding to the size of 
the HmuY’ fusion protein was observed (Fig. 4.15B, lane 1) which indicates 
peroxidase activity as a result of hemin bound to HmuY’. Negative control using GST 
alone incubated with hemin, (Fig. 4.15B, lane 3) showed that GST was not able to 
bind hemin and thus the hemin-binding activity detected in Fig. 4.15B, lane 1, was 
due to HmuY’ alone. Negative control of HmuY’ incubated without hemin did not 
give any bands (Fig. 4.15B, lane 4) indicating absence of any inherent peroxidase 
activity of the HmuY’ protein. Thus, peroxidase activity detected in Fig. 4.15B, lane 1, 
was a result of the true hemin-binding activity of HmuY’. Almost no activity was 
detected in HmuY fusion protein as shown by the absence of dark bands around the 
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4.11.2. Hemin-binding assay of proteins with GST tags removed 
Since the 26 kDa GST tag was considered relatively large compared to the 16 
kDa size of HmuY, presence of the GST tag may affect proper folding and thus 
hemin-binding activity of the HmuY fusion protein. Thus we assayed the recombinant 
proteins without their GST tags for hemin-binding activity as above. 
Fig. 4.15C shows the LDS-PAGE gel (stained in Coomassie blue) of the 
recombinant proteins without the GST tag. Fig. 4.15D shows a duplicate of this LDS-
PAGE gel stained with TMBZ. A darkened band of ~26 kDa and ~50 kDa was 
observed for HmuY’ (Fig. 4.15D, lane 1) indicating hemin-binding activity of HmuY’. 
The ~50 kDa band was likely to be due to dimerization as this band was only present 
under non-reducing conditions in the absence of β-mercaptoethanol and without 
heating. Still little hemin-binding activity was observed for HmuY without the GST 
tag as shown by the almost non-visible bands of ~16 kDa and ~30 kDa in Fig. 4.15D 
lane 2, which indicates very little peroxidase activity and thus little hemin-binding. 
The faint 30 kDa band observed for HmuY was also likely to be due to dimerization 
of the protein. These results rule out the effect of the GST protein on the folding and 





















HmuY   1 MALHRYDVRLNCGESGKGKGGAVFSGKTEMDQATTVPTDG-Y-TVDV-LGRITVK 52             
24 kDa protein                              DQATSVPTDGXYXTVDXKLGRITVK  
fragment 1              
 
HmuY  53 YEMGPDGHQMEYEEQGFSEVITGKKNAQGFASGGWLEFSHGPAGPTYKLSKRVF 106  
24 kDa protein GPDGHZMEYEE 
fragment 2   






Fig. 4.14. Alignment of HmuY protein with peptide sequences obtained from 
cyanogen bromide fragmentation of a 24 kDa hemin-binding protein described 
































Fig. 4.15. LDS-PAGE and TMBZ staining for hemin-binding proteins. (A) LDS-
PAGE of GST fusion recombinant proteins, stained in Coomassie blue. Lane MW: 
Protein molecular weight marker, unstained. (Fermentas), Lane 1: GST-HmuY’, Lane 
2: GST-HmuY, Lane 3: GST alone. (B) LDS-PAGE gel (duplicate of gel (A)), stained 
in TMBZ. Lane 1: GST-HmuY’ with hemin, Lane 2: GST-HmuY with hemin, Lane 3: 
GST alone with hemin, Lane 4: GST-HmuY’ without hemin. (C) LDS-PAGE gel of 
recombinant HmuY’ and HmuY after removal of GST tags. Lane MW: Protein 
molecular weight marker, unstained. (Fermentas), Lane 1: HmuY’, Lane 2: HmuY. (D) 
LDS-PAGE gel (duplicate of gel (C)), stained in TMBZ. Lane 1: HmuY’ with hemin, 
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4.12 Construction of a  hmuY’ isogenic mutant of P. gingivalis 
To better elucidate the function of HmuY’ in vivo, a P. gingivalis isogenic 
mutant was created by insertional inactivation of the hmuY’ gene with an 
erythromycin (ermF) cassette by allelic exchange (Fig. 4.16). 
 
4.12.1. Construction of plasmid for insertion inactivation of hmuY’ 
A plasmid containing the hmuY’ gene interrupted with an ermF cassette was 
first constructed. The ermF cassette with its flanking sequences (Fletcher et al., 1995) 
was amplified from the plasmid, pVA2198, using ermF_ClaI_Fwd and 
ermF_ClaI_Rev primers (Table 3.1). The expected size of 1183 bp for the ermF 
cassette was obtained (Fig. 4.17A). 
The hmuY’ gene (651 bp) was then amplified and cloned into the pGEM-T 
vector (3 kb) via TA cloning. Resultant pGEMT-hmuY’ plasmid was checked by 
restriction digest with ClaI, which was a unique site present in hmuY’ but not in the 
pGEM-T vector. A single band of 3651 bp was obtained for the restriction digest as 
expected (Fig. 4.17B).  
The ermF cassette was then inserted into pGEMT-hmuY’ at the unique ClaI 
site within hmuY’. Clones harboring the resultant plasmid, pGEMT-hmuY’-ermF, 
were screened by PCR, using hmuY’_Fwd and ermF_ClaI_Rev primers to check for 
insertion of the ermF cassette in the right orientation, as well as, by digestion with 
restriction enzyme, ClaI. Clones with the correct insertions gave an expected band of 
~1315 bp for the PCR, which corresponds to the combination of the 132 bp of the 5’ 
end of hmuY’ (up to the ClaI site) with the 1183bp fragment of the ermF cassette (Fig. 
4.18A). Agarose gel analysis of digested fragments with ClaI also gave the expected 
sizes of linearised pGEMT-hmuY’ and the ermF cassette, which were ~3615 bp and 
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~1183 bp respectively (Fig.4.18B). This indicates presence of the correct insert and 
vector. To further confirm this and to ensure that there were no mutations in both 
ermF and hmuY’ sequences, DNA sequencing was also carried out (results not shown).  
 
4.12.2. Isolation of hmuY’ isogenic mutants 
To obtain isogenic mutants defective in hmuY’, the plasmid pGEMT-hmuY’-
ermF was linearised, transformed by electroporation into P. gingivalis W50 and 
transformants were selected on plates containing erythromycin. Since the plasmid was 
linear, erythromycin-resistant transformants would arise mainly as a result of a 
double-crossover event between the regions flanking the ermF marker and the wild-
type hmuY’ gene on the chromosome (Fig. 4.16). This would result in replacement of 
the segment of the wild-type gene with a fragment conferring erythromycin resistance 
(ermr).  
A small number of false positive transformants may arise as a result of 
recircularization of the plasmid. PCR and Western blot analyses were carried out to 
rule out these false positive mutants as described in detail in section 4.13.  
Fifteen ermr colonies were detected after a five-day incubation.    
 
4.13 Characterization of hmuY’ isogenic mutant of P. gingivalis  
The ermr colonies were first checked by PCR using various primer pairs (Fig. 
4.19).  To rule out false positive mutants that may have arisen due to recircularization 
of the plasmid, as well as to verify insertion of the ermF cassette at the desired 
location on the genome, PCR was carried out using primers (hmuY’_5’UTR or 
hmuY’_3’UTR) which target sequences outside of those used for  recombination                        
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Fig. 4.17. PCR of ermF cassette and restriction analysis of pGEMT-hmuY’. (A) 
PCR product of ermF cassette with ClaI restriction sites flanking cassette. Lane MW: 
2-log DNA ladder (NEB), Lane 1: ermF cassette amplification product. (B) 
Restriction digestion of pGEMT-hmuY’. Lane MW: 2-log DNA ladder (NEB), Lane 1: 
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Fig. 4.18. Agarose gel analysis of plasmid pGEMT-hmuY’-ermF used for the 
construction of a P. gingivalis hmuY’ mutant. (A) PCR analysis of pGEMT-hmuY’-
ermF with hmuY’_Fwd and ermF_ClaI_Rev. Lane MW: 2-log DNA ladder (NEB), 
Lane 1: PCR product of 5’ end of hmuY’ with ermF cassette. (B) Restriction digestion 
of pGEMT-hmuY’-ermF. Lane MW: 2-log DNA ladder (NEB), Lane 1: undigested 
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(i.e. sequences flanking hmuY’). 
 Fig. 4.19A , lane 2 shows that PCR of a true positive mutant, PgY’1, using 
primers hmuY’_5’UTR and hmuY_Rev gave a 1990 bp fragment as expected. A wild 
type or a false positive mutant will give a fragment of 807 bp, corresponding to the 
wild type sequence (Fig. 4.19B, lane 2). PCR with primer pairs 
hmuY’_5’UTR/ermF_ClaI_Rev and ermF_ClaI_Fwd/hmuY’_3’UTR also confirm 
the true integration (Fig. 4.19A, lanes 4 and 5).  
To further confirm presence of the ermF cassette at the right location and at 
not more than one site, Southern blot analyses were also carried out on BamHI-
digested genomic DNA of the true positive transformants, using probes specific for 
hmuY’, as well as, ermF. As shown in Fig. 4.20, Southern blot analysis of one 
representative mutant, PgY’1, with the hmuY’ probe shows the predicted fragment of 
~3516 bp, which was ~1.2kb larger than the 2333bp band of the wild-type, due to 
insertion of the ermF cassette. A similar blot with the probe for ermF revealed a 
single and identical band of ~3516 bp in PgY’1, confirming insertion of ermF at only 
a single location (Fig. 4.20). No band was observed for the wild type using the ermF 
probe as expected. 
SDS-PAGE (Fig. 4.21A) and Western blot analysis (Fig. 4.21B) were also 
carried out to further characterize the mutant. False positive mutants harboring a 
recircularized plasmid or containing non-specific integration of the ermF cassette will 
possess an intact 24kDa HmuY’ protein. Absence of the 24 kDa band in the mutant 
PgY’1 compared to the wild type, confirms specific intergration of the ermF cassette 
to “knock-out” expresion of hmuY’ and further confirms that the 24 kDa protein is 
indeed encoded by hmuY. 
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Fig. 4.19. PCR analysis of P. gingivalis isogenic mutant defective in hmuY’, PgY’1, 
and wild type, W50. (A) PCR to check for insertion of ermF cassette in P. gingivalis 
mutant PgY’1 with various primers. (B) PCR of P. gingivalis W50 wild type with 
same primers as in (A) and in the same order. Lane MW: 2-log DNA ladder (NEB), 
Lane 1: PCR with hmuY’_Fwd/hmuY_Rev, Lane 2: PCR with 
hmuY’_5’UTR/hmuY_Rev, Lane 3: PCR with hmuY’_Fwd/ermF_ClaI_Rev, Lane 4: 






  Expected size (bp) 
Lane  Primer pair For mutant For wild type 
1 hmuY’_Fwd/hmuY_Rev 1834 651
2 hmuY’_5’UTR/hmuY_Rev 1990 807
3 hmuY’_Fwd/ermF_ClaI_Rev 1312 NIL
4 hmuY’_5’UTR/ermF_ClaI_Rev 1468 NIL
5 ermF_ClaI_Fwd/hmuY_3’UTR 1845 NIL
 MW   1     2    3    4     5 
PCR of P. gingivalis mutant 
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Fig. 4.20. Southern blot analyses of P. gingivalis mutant, PgY’1, and wild type 
W50 using probes specific for hmuY’ and ermF. (A) Southern blot analysis of 
genomic DNA hybridized with probe for hmuY’. (B) Southern blot analysis of 
genomic DNA hybridized with probe for ermF. Lane MW: DNA molecular weight 
marker II, DIG-labeled (Roche), Lane PgY’1: Genomic DNA from P. gingivalis 



















































































Fig. 4.21. SDS-PAGE and Western blot analyses of P. gingivalis W50 wild type 
and mutant, PgY’1. (A) SDS-PAGE stained in Coomassie blue, and (B) Western blot 
analysis using HmuY peptide-specific antiserum of P. gingivalis W50 wild type (Lane 

















Chapter 4 Results 
4.14 Growth of hmuY’ isogenic mutant vs wild-type under hemin-excess and 
hemin-limited conditions 
Since HmuY’ was found to possess hemin-binding ability, we hypothesized 
that this gene was important in hemin uptake for the growth of P. gingivalis. Thus, the 
ability of PgY’1 to grow with hemin as the main iron source was examined. Growth of 
PgY’1 mutant was compared to wild type under hemin-excess (5 μg/ml hemin) and 
hemin-limited (0 μg/ml hemin) conditions. Growth of all cultures were followed 
through until the growth of the mutants reached stationary phase under hemin-limited 
conditions (~49h). 
Growth profiles of both mutant and wild type were found to be similar under 
hemin-excess conditions, with a final OD600 of ~2.0 (Fig. 4.22). This indicates that the 
mutation was not detrimental to normal functions of the bacterial cells. However, 
growth of PgY’1 was significantly affected under hemin-limited conditions compared 
to the wild type. The final OD600 of PgY’1 mutant grown under hemin-limited 
conditions was only 0.42±0.06 compared to 0.86±0.062 of the wild type (Fig. 4.22). 
These results show that HmuY’ is important for the growth of P. gingivalis especially 
under conditions of low hemin availability. 
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Fig. 4.22. Growth profiles of P. gingivalis wild type W50 and mutant, PgY’1, 
under hemin-excess (5 μg/ml hemin) and hemin-limited (0 μg/ml hemin) 




































Chapter 4 Results 
4.15 Transcription regulation of hmuY’ in P. gingivalis 
Since HmuY’ protein was found to bind hemin and was important for growth 
under hemin-limited conditions, we sought to determine if hmuY’ gene was regulated 
in response to varied hemin concentrations as well as different growth phases at the 
transcriptional level. P. gingivalis W50 was grown under hemin-excess (5 μg/ml 
hemin) and hemin-limited (0 μg/ml) conditions. Samples were then taken at early-, 
mid- and late-log phases of growth (6 h, 17 h and 30 h respectively) for each hemin 
concentration and the amount of hmuY’ transcript was examined across all samples by 
Northern blot analysis.  
Results show that hmuY’ was down-regulated significantly at late-log phase 
when cells were grown under hemin-excess conditions (Fig. 4.23B).  However under 
hemin-limited conditions, hmuY’ was upregulated at early-, mid- and late-log phases 
of bacterial growth (Fig. 4.23B). These results suggest that hmuY’ was regulated by 
availability of hemin in the environment as well as by growth phase changes. 
100 
 














































Fig. 4.23. Transcription regulation of hmuY’. (A) Growth curve of P. gingivalis 
W50 under hemin-excess (5 μg/ml hemin) and hemin-limited (0 μg/ml hemin) 
conditions. Arrows indicate samples taken at various time points (different growth 
phases) for RNA isolation. (B) Northern blot analysis of total RNA of P. gingivalis 
W50 from early-, mid- and late-log phases of growth (6h, 17h, and 30h respectively) 
under hemin-excess (5 μg/ml hemin)  and hemin-limited conditions (0 μg/ml hemin), 
using the probe specific for hmuY’. (C) Ethidium bromide-stained gel of 16S rRNA, 






























Chapter 4 Results 
4.16 HmuY’ is localized to outer cell surface of P. gingivalis 
To give us an insight into the possible cellular localization of HmuY’, 
transmission electron microscopy (TEM) was performed on immunogold-labeled P. 
gingivalis whole cells which had been grown to mid-log phase in standard Pg broth  
containing 5 μg/ml hemin. HmuY’ was observed to be located mostly on the outer 
cell surface on most of the P. gingivalis cells (Fig. 4.24, left diagram, arrows). 
Negative control using pre-immune serum as the primary antibody displayed 
negligible gold particles (Fig. 4.24, right inset).  
The localization of HmuY’ is consistent with the role of HmuY’ as a putative 
lipoprotein, which is usually localized on the outer cell surface, where it may serve to 
facilitate transport of hemin into the bacterial cell for growth. 
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Fig. 4.24. Localization of HmuY’. Transmission electron micrograph of P. gingivalis 
W50 with immuno-gold labeling of HmuY’(left, arrows) at magnification of 60 000 x. 
(Inset) Negative control of immuno-gold labeling with pre-immune serum as primary 









Chapter 5 Discussion 
Chapter 5  
Discussion 
hmuY was first identified by Simpson et al. (Simpson et al., 2000) as a 
putative ORF of 429 bp, coding for a protein of 143 amino acids. Other than knowing 
its genomic location upstream of the TonB-dependent hemin/hemoglobin receptor 
HmuR, little characterization has been performed on this putative ORF. Only recently, 
recombinant protein HmuY was expressed and found to possess hemin- and ATP-
binding function (Olczak et al., 2006). However, as only recombinant proteins were 
used, there was no evidence of HmuY protein expression in vivo in P. gingivalis cells.   
 
5.1 Expression of HmuY in P. gingivalis 
Since little is known about the HmuY protein in vivo, we first sought to 
determine if a protein was expressed from this putative ORF in P. gingivalis cells. 
Using HmuY peptide-specific antiserum, Western blot analysis was carried out to 
detect the presence of HmuY protein in the P. gingivalis W50 whole cell lysate. The 
predicted molecular weight of HmuY was 16 kDa, however, a 24 kDa band was 
detected instead (Fig. 4.1). 
This difference of 8 kDa was quite large and unlikely to be due to post-
translational modification of the HmuY protein. It was also unlikely to be due to 
dimerization of the protein or association of this protein with other proteins as the 
protein samples were heated and separated under denaturing conditions in the 
presence of a reducing agent, β-mercaptoethanol. Thus, the other likely possibilities 
of detecting a band different from the predicted molecular weight are: (1) the presence 
of a homologue of the protein which possessed similar peptide sequences or (2) cross-
reactivity of the antiserum with other similar proteins.  
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5.2 Confirmation of protein identity by mass spectrometry 
To rule out cross reactivity of the antiserum and to confirm the identity of the 
band, tandem mass spectrometry (MS/MS) was carried out.  Single-stage mass 
spectrometers (MALDI-TOF MS) have been used to determine the accurate masses of 
peptides generated by digest of proteins, usually with trypsin. This peptide mass 
fingerprint (PMF) generated allows identification of a protein based on the specific 
group of peptide masses it produces (Liebler, 2002). With MALDI-tandem mass 
spectrometers (MALDI-TOF-TOF MS), further information on the individual peptide 
sequence can be obtained, giving a more accurate identification of the unknown 
protein (Bienvenut et al., 2002). 
 Analysis of the peptide mass fingerprint of the 24 kDa protein gave numerous 
peptide masses that correspond to most of the peptides present in the HmuY protein 
(Fig. 4.2, Table 4.1). This extensive ‘coverage’ of peptides from the PMF analysis 
(Fig. 5.1) gives us high confidence that the 24 kDa protein band is indeed very similar 
to HmuY which was also reflected by the high score and low E-value of the Mascot 
search (Appendix II).  
Furthermore, selected peptides were analyzed through the second-stage of 
fragmentation (MS/MS) which allows the sequence of the peptides to be determined. 
The MS/MS spectra (not shown) were searched automatically against the sequences 
in the database and their ions scores were returned (Table 4.1). The higher the ions 
score, the higher the confidence of the match of the sequence determined by the 
spectra to those in the database. A threshold score of 65 indicates a 1 in 20 chance (5 
%) of a false positive match (Perkins et al., 1999). A good score of >100 was obtained 
for two of the peptides, indicating >95 % confidence of the sequence match (Table 
4.1). These sequences were thus confirmed to be present in the 24 kDa protein. 
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Together, these data confirmed that the sequence of the 24 kDa protein was almost 
identical to the HmuY protein except for the difference in molecular weight.  
Thus the most likely reason for this was that the protein was expressed from a 
gene sequence that was larger than the previously suggested hmuY. 
 
5.3 Discovery of a larger open-reading frame, hmuY’   
Sequence analysis of the P. gingivalis W83 genome led to the discovery of a 
translational start codon (ATG) located 222 bp upstream of the previously suggested 
hmuY translational start codon. This new start codon was found to be in-frame with 
the hmuY translational stop codon (TAA), thus giving rise to a new ORF (Fig. 4.3). 
As we cannot rule out the function of the smaller ORF hmuY or the existence of the 
HmuY protein at this stage, the larger ORF was designated as hmuY’. Presence of a 
putative Shine-Dalgarno site shortly upstream of the previously suggested hmuY 
sequence, suggests that it is possible for the HmuY protein to be expressed which may 
occur in much lower quantities or only under particular conditions. The hmuY’ 
sequence has been deposited under Genbank Accession no. EF055489.  
hmuY’ was predicted to code for a protein of 23.8 kDa (Bjellqvist et al., 1994; 
Bjellqvist et al., 1993), which was similar to the molecular weight of the band we had 
detected. With the deduced amino acid sequence of HmuY’, peptide mass prediction 
was carried out using the PeptideMass prediction software (Wilkins et al., 1997)  and 
results (Appendix II) were compared with the peptide mass fingerprint (Fig. 4.2) of 
the 24 kDa protein obtained from mass spectrometry. Matching peptide masses and 
sequences were found between the predicted data and that from the mass spectrometry 
data (Fig. 4.2 and Fig. 5.1). Taken together, these results strongly suggest that hmuY’ 
is the gene sequence coding for the 24 kDa protein detected above. 
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  1 MKKIIFSALC ALPLIVSLTS CGKKKDEPNQ PSTPEAVTKT VTIDASKYET    
 51 WQYFSFSKGE VVNVTDYKND LNWDMALHRY DVRLNCGESG KGKGGAVFSG 
101 KTEMDQATTV PTDGYTVDVL GRITVKYEMG PDGHQMEYEE QGFSEVITGK 
151 KNAQGFASGG WLEFSHGPAG PTYKLSKRVF FVRGADGNIA KVQFTDYQDA 






Fig. 5.1. Amino acid sequences of HmuY’ and HmuY showing the coverage of 
peptides matched from the mass spectrometry analysis. Peptides from HmuY 
matched by Mascot are in red. Peptides from HmuY’ predicted to match the mass 














Chapter 5 Discussion 
Although the strain we were working on (strain W50) was closely related to 
the strain W83 used for sequencing in the NCBI database (Chen and Slots, 1994), 
differences had been observed in the outer membrane proteins between the two strains 
(Kennell and Holt, 1990). So DNA sequencing was performed on the regions flanking 
hmuY in strain W50 (results not shown) and sequences were confirmed to be identical 
to that of strain W83 before proceeding with further analyses. The genomic 
organization of these genes was also confirmed in strain W50 via Southern blot 
analysis so as to rule out the possibility that hmuY’ or hmuY or similar sequences were 
present at more than one location on the genome. Results confirmed that hmuY’ and 
hmuY were present as a single copy and were overlapped on the same segment of the 
genome in strain W50 (Fig. 4.4), similar to that obtained by sequence analysis of 
strain W83 (results not shown). 
  
5.4 Transcript analyses of hmuY’ and hmuY 
Since hmuY’ and hmuY were present on the same segment of the genome, the 
transcription organization of these two ORFs was investigated to determine if there 
were alternative transcripts that may give rise to expression of the smaller protein, 
HmuY.    
Northern blot analysis was first carried out to look at the transcripts of hmuY’ 
and hmuY using probes specific for their respective sequences. A single band of the 
same size of ~750 bp was obtained for both probes (Fig. 4.5B). No distinct alternative 
transcripts of the shorter ORF hmuY were observed, suggesting that only a single 
transcript containing both hmuY’ and hmuY was present. The transcript size of ~750bp 
was only slightly larger than the 651 bp size of hmuY’, suggesting that hmuY’ was co-
transcribed with hmuY, but not with the downstream gene, hmuR.  
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 Previously, Simpson et al. (Simpson et al., 2000) had suggested that hmuY 
was co-transcribed with hmuR through RT-PCR in strain A7436. This was contrary to 
our results based on Northern blot analyses above, which may be a result of strain 
differences. To investigate this, RT-PCR was also performed on strain W50. Although 
the 2.6 kb hmuY’-hmuR transcript was also obtained in W50, the band was faint 
despite using almost 1 μg of total RNA as the starting material (Fig. 5.2). This 
suggests that the full-length transcript was present but only in very low quantities in 
strain W50. This may explain the absence of the full-length transcript in the Northern 
blot analysis as it was present in undetectable amounts. Although RT-PCR was more 
sensitive, the Northern blot analysis gave a better quantitative indication of the actual 
transcript amounts in the cells and the results clearly show that the shorter transcript 
was the more abundant transcript in strain W50. This difference observed in the 
transcription organization between the strains suggests possible variations in the 
expression of this gene in different strains.  
 
5.5 Transcription start site mapping and analysis of promoter region of 
hmuY’ 
Although the Northern blot analyses indicated that hmuY’ and hmuY were on 
the same transcript and no alternative transcripts of hmuY alone were found, we 
wanted to confirm this. Thus the transcriptional start sites of both hmuY’ and hmuY 
were mapped using a modified primer extension assay. This assay not only allows us 
to determine the putative promoter region of the genes but also to confirm if there 
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Fig. 5.2. RT-PCR of hmuY’ and hmuY’-hmuR. Lane M: 2-log DNA ladder; Lane 1: 





Chapter 5 Discussion 
This modified assay relies on the same principle as the conventional primer extension 
assay where the reverse transcriptase was used to extend a DNA primer until the 5’ 
end of the mRNA template. By knowing the size of this cDNA product, the 5’ end of 
the mRNA, corresponding to the transcriptional start site, can be determined. In this 
modified assay, the DNA primers are labeled with a fluorescent dye (6-FAM) instead 
of radioactive isotopes. Accurate size determination of the primer extension products 
was performed using the capillary electrophoresis system of the ABI Genetic 
Analyzer instead of acrylamide gels. These modifications provided the advantage for 
the elimination of the use of radioactive substances, in addition to hazardous 
chemicals such as acrylamide. 
One disadvantage of this modified assay was that the sequence of the products 
could not be compared, unlike the conventional primer extension assay where dideoxy 
sequencing reactions of the products can be run alongside the same gel as the primer 
extension products. However, this was circumvented with the use of two different 
primers (hmuY’_Rev_6FAM and hmuY_Rev_6FAM) which can help increase 
specificity and confidence of the mapping.  
The primer, hmuY_Rev_6FAM, serves a dual purpose in our assay. It was 
used to determine the presence of alternative transcripts of hmuY and their respective 
transcription start sites, as well as, to confirm transcription start site mapping of 
hmuY’. The primer extension products obtained using these two primers displayed 
clean, distinct peaks (Fig. 4.6A and C), indicating that the products obtained were 
specific. Although some peaks of lower intensities were observed for 
hmuY_Rev_6FAM, the heights of these peaks were far below that of the primer 
extension product obtained (Fig. 4.6C). This indicates that these products were 
present in negligible amounts when compared to the extension product. This could be 
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due to overloading of the sample such that some non-specific products were also 
detectable. This also reflects the sensitivity of this method and the absence of any 
other peaks of significant height indicates that there were indeed no alternative 
transcripts of hmuY.  
In this method, the accuracy of the size determination by the Genetic Analyzer 
was also crucial, thus this was confirmed by the RT-PCR products (Fig. 4.6B and D) 
with their known product sizes. Sizes of the RT-PCR products determined by this 
method corresponded very well to their expected sizes indicating accuracy of the size 
determination. 
Using the above method with different reverse primers, the transcriptional 
start site of both hmuY’ and hmuY was mapped to the same nucleotide, which was an 
adenosine residue 27 bp upstream of the hmuY’ translational start codon (Fig. 4.7). 
The predicted size of mRNA from this transcript start site to the proposed rho-
independent terminator loop was also in agreement with the Northern blot analysis 
results, which showed a transcript size of ~750 bp, indicating further the accuracy of 
the transcription start site mapping and a role for the terminator loop in regulating the 
transcription of this ORF.   
 
5.6 Putative promoter sequences of hmuY’ 
After determination of the transcription start site, the upstream sequence was 
analyzed for putative promoter coding sequences to give us a better insight into the 
possible regulatory mechanisms of hmuY’ expression.  
Recently, a consensus for P. gingivalis promoter sequences was identified. It 
was found to have a potential -10 hexamer sequence of 5’-TATATT-3’ (known as 
P3”), which is repeated at -19/20 nucleotides (known as P3’), and an upstream 
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consensus sequence of 5’-CAGAT(A/G)-3’ (known as P5’), which was centered at -
39/40 nucleotides (Jackson et al., 2000). Putative promoter sequences based on these 
consensus sequences were identified and were indicated in Fig. 4.7. A sub-sequence, 
5’-TTGC-3’, has been found in association with the P3” promoter element of many of 
the P. gingivalis genes (Jackson et al., 2000). This sequence was also found at the P3” 
element of the promoter region of hmuY’ (Fig. 5.3).  
Further, a consensus sequence 5’-TAXXTTTG-3’, which occurs within 15 
nucleotides upstream of the +1 site, has been reported for Bacteroides fragilis 
promoters (Bayley et al., 2000) and also found upstream of transcriptional start sites 
of Prevotella spp. (Manch-Citron et al., 1999). This consensus sequence has a high 
level of similarity with the P3” element of hmuY’ and other P. gingivalis genes. This 
similarity suggests that there may be a common RNA polymerase promoter 
recognition sequence present in these organisms, which are all part of the 
Bacteroidaceae family. A role for the P3” element in P. gingivalis promoter function 
has also been indicated by an increase in activity of the fimA promoter following 
mutation of nucleotides -9 to -11 from TAA to GCC (Xie and Lamont, 1999) (Fig. 
5.3).  Thus, the presence of this P3” element in the promoter region of hmuY’ may 
play a role in the expression of this gene, although details of such regulation will 
require further investigations. 
Most genes that are involved in iron or hemin utilization are usually regulated 
by the ferric uptake regulator (Fur) protein (Andrews et al., 2003). This Fur regulator 
protein usually binds to consensus sequences, known as Fur boxes (E. coli consensus 
sequence: 5’-GATAATGATAACATTATC-3’), at the promoter region of the gene it 
regulates and acts as a transcription repressor (Escolar et al., 1998). The Fur box has  
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                            P5’                     P3’     P3”     
 
rgpA  CATATTTTGATTCGCGTTT……AAAGGAAAAGTGCATATATTTGCGATTg.... 
               P5’                 P3’       P3”   
 
kgp       TATAATCCGATACTCTTCT.TAAATCGAATTTTTTCTCAAATTGCGCCGc.... 
               P5’                    P3’      P3”    
 
fimA     TTTTTCTTGTTGGGACTTGCTGCTCTTGCTATGACAGCTTGTAACAAAGACAa.... 
    P5’     P3’      P3” 
 
Consensus     ………CAGAT(A/G)……………………TATATTNNNTATATT……… 
          P5’             P3’      P3” 
 
  
Fig. 5.3. Promoter regions of hmuY’, rgpA, kgp and fimA. Transcription start site is 
marked on the right end with small caps. Putative promoters P5’, P3’ and P3” 
corresponding to the consensus sequences of that of P. gingivalis, as determined by 
Jackson et al. (2000), are indicated and underlined. Similar subsequence ‘TTGC’ is in 
bold. Nucleotides mutated to determine role of P3” element in promoter function of 
fimA are indicated in blue. Mutation of these nucleotides from TAA to GCC was 
found to cause an increase in expression of fimA (Xie et al., 1999). 
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been known to be conserved among various species of bacteria (Escolar et al., 1999). 
Although hmuY’ is found to be involved in hemin utilization, no homologous Fur box 
sequence was found upstream of our mapped transcription start site. This suggests 
that hmuY’ was not subject to regulation by the Fur protein.  
 
5.7 HmuY’ possesses stronger hemin-binding ability than HmuY 
HmuY was found to possess similarities to peptides of a hemin-binding 
protein described by Kim et al.(Kim et al., 1996) (Fig. 4.14). Thus it was 
hypothesized that HmuY’ and HmuY may possess hemin-binding properties as well.  
Indeed, recombinant HmuY’ was found to possess strong hemin-binding 
ability (Fig. 4.15). However, HmuY was shown to demonstrate diminished hemin-
binding ability as compared to HmuY’ (Fig. 4.15B, lane 2 and D, lane 2). This can be 
inferred from the reduced intensity of TMBZ staining, despite the presence of almost 
equal or slightly larger amounts of HmuY proteins per well as indicated by the 
Coomassie blue-stained gels (Fig. 4.15A and C). In our study, the GST protein fusion 
tag alone was shown to have no effect on hemin-binding for both HmuY’ and HmuY, 
and removal of this tag provided further evidence for the true hemin-binding property 
of HmuY’. During the course of our study, recombinant HmuY was also reported to 
be expressed in E. coli and insect cells, and found to possess hemin-binding properties 
via  different methods of UV-Vis analysis and affinity chromatography using hemin-
agarose (Olczak et al., 2006). This compliments our findings. 
An additional band of ~50 kDa was observed when HmuY’, after removal of 
the GST tag, was run on LDS-PAGE under non-reducing conditions (Fig. 4.15D, lane 
1). This was likely to be a result of dimer formation of HmuY’. A faint 30 kDa band 
was also observed in our recombinant HmuY. This was also consistent with results of 
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Olczak et al. (Olczak et al., 2006) where dimeric forms of recombinant HmuY were 
also observed when it was expressed in E. coli and insect cells. Such dimerization was 
suggested to play a role in aggregation of the low concentrations of HmuY for its 
putative function (Olczak et al., 2006). It can be implied from the above results that 
the C-terminal portion of the protein was sufficient to cause dimerization, as the 
smaller HmuY was able to form dimers, even without the additional amino acids at 
the N-terminal of HmuY’. However, further experimental evidence will be required to 
determine the domains necessary for various functions of HmuY’ as well as the 
presence and purpose of such dimerizations in vivo. 
The hemin-binding protein, described by Kim et al.(Kim et al., 1996) which 
possessed peptides similar to HmuY was reported to be 30 kDa when unheated and 24 
kDa after heating. Since HmuY’ was identical to HmuY at the C-terminus and the 
size of HmuY’ was similar to this protein, it was likely that this 24-kDa protein, 
which was described in P. gingivalis 381, and HmuY’ may be the same protein. 
However, as no gene sequence of the other protein was available, more evidence is 
needed to determine if it was a homologue or an identical protein to HmuY’. Other 
than this other 24 kDa hemin-binding protein, a search of the databases did not find 
HmuY’ to be homologous to any other hemin-binding proteins nor were there any 
domains with significant similarity to other iron acquisition proteins. Similarities were 
found mainly between HmuY’ and hypothetical proteins or putative lipoproteins. 
Most of these putative proteins were found in closely related species such as 
Bacteroides fragillis NCTC9343 (BF1028, 54% similarity), Bacteroides fragillis 
YCH46 (BF2687, 46% similarity), Bacteroides thetaiotaomicron (BT0497, 46% 
similarity and Prevotella intermedia 17 (PIN0009, 37% similarity). It is therefore not 
unreasonable to speculate that these proteins may represent a novel or unique class of 
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hemin-binding proteins. Thus, understanding the function of HmuY’ may be helpful 
in giving us insight to hemin uptake in these organisms as well. 
 
5.8 HmuY’ is important for hemin-uptake for growth of P. gingivalis 
After recombinant HmuY’ was shown to demonstrate hemin-binding 
properties, we were interested to find out the function of HmuY’ in vivo. To 
investigate this, an isogenic mutant defective in hmuY’, PgY’1, was created. This was 
done by insertion of an erythromycin (ermF) cassette into the ClaI site of hmuY’ by 
allelic exchange, thereby disrupting the gene (Fig. 4.16).  
Successful replacement of the chromosomal hmuY’ gene with a copy disrupted 
with the ermF cassette was verified by PCR as well as Southern blot analyses (Fig. 
4.19 and 4.20).  Further confirmation of the disruption of the gene and protein 
expression was proven by Western blot analysis, which showed absence of the 24 kDa 
HmuY’ in the mutant PgY’1 (Fig. 4.21).  The results further confirmed that hmuY’ is 
indeed the gene sequence coding for the 24 kDa protein detected initially in the P. 
gingivalis whole cell lysate.  
The function of HmuY’ in vivo was investigated by comparing growth of the 
mutant deficient in HmuY’, PgY’1, versus wild-type when hemin was used as the 
main iron source. When grown under hemin-excess conditions, both mutant and wild-
type showed similar growth profiles (Fig. 4.22). This indicated that mutation of 
hmuY’ did not affect the normal function of the cells under hemin-excess conditions. 
This suggests that HmuY’ was not essential for the uptake of hemin under hemin-
excess conditions. This was not surprising as the presence of other hemin-uptake 
proteins (e.g. RagB (Hanley et al., 1999), IhtB (Dashper et al., 2000) and Tla 
(Slakeski et al., 2000)) were able to compensate for the lack of HmuY’. As hemin was 
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in abundance, the amount of hemin uptake in the absence of HmuY’ was not 
significantly reduced, thus growth was not adversely affected.   
However under hemin-limited conditions, the mutant PgY’1 demonstrated 
significant retardation in growth when compared to the wild-type (Fig. 4.22). This 
suggests that HmuY’ was essential for the growth of P. gingivalis under conditions of 
poor hemin availability. Under such conditions, when HmuY’ was absent, cells were 
unable to cope with this stress of hemin limitation, even in the presence of other 
hemin-binding proteins, perhaps due to the lower rate of hemin-uptake or lowered 
ability to scavenge the heme in the media and thus growth was significantly affected. 
Thus these results clearly show the importance of HmuY’ in hemin-uptake, without 
which cells are unable to survive under low hemin conditions. This is of significant 
importance since P. gingivalis cells are often subject to conditions of such low hemin 
availability as hemin and iron are not available freely within the human host. Thus, 
increased concentrations of hemin-receptors, such as HmuY’, are crucial to efficiently 
scavenge and compete for the hemin from the host heme-binding proteins. 
In vivo, iron can be provided by sources other than hemin, such as iron-
binding serum proteins (transferring and lactoferrin) and red blood cells (RBCs). 
However, since the main source of iron for P. gingivalis is still derived from hemin 
(Bramanti and Holt, 1991), under different iron-depleted conditions, we can 
hypothesize that growth of P. gingivalis is still likely to depend largely on functional 
hemin receptors such as HmuY’.  
Studies have also shown that the ability of P. gingivalis to multiply in vitro 
under iron-limiting conditions may be correlated to its ability to induce infections in 
an animal model (Grenier et al., 2001). P. gingivalis isolates that possessed a lower 
requirement for iron were likely to have a higher potential for initiating periodontal 
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infections. Thus, HmuY’ may play a role as an agent in causing high virulence 
potential of P. gingivalis W50 in initiating infections, by increasing its ability to 
scavenge heme from the host, thereby allowing the organism to survive under lower 
iron and heme conditions.  
 
5.9 hmuY’ is regulated by both growth phase and hemin availability at the 
transcript level  
To better understand the mechanism governing hemin-uptake in P. gingivalis 
W50, regulation of hmuY’ at the transcript level was investigated. The effect of hemin 
concentration and growth phase on the regulation of hmuY’ transcript was 
investigated by growing cells under hemin-limited and hemin-excess conditions and 
samples taken at early-, mid- and late-log phases.  
To investigate the effect of growth phase on hmuY’ regulation, amount of 
hmuY’ transcript was compared across early-, mid- and late-log growth phases under 
hemin-excess conditions (Fig. 4.23B). Since gene expression often correlates with 
protein expression in bacteria, we can hypothesize that differences in transcript levels 
is likely to reflect differences in protein amount. hmuY’ was observed to be 
significantly down-regulated at late-log phase which suggests that hmuY’ transcription 
was regulated by growth. This was further suggested by Western blot analyses (using 
HmuY peptide-specific antiserum) of cell lysates of P. gingivalis W50 which were 
grown to mid-log and late-log phases under hemin-excess conditions (Fig. 5.4). 
Protein expression of hmuY’ was observed to be down-regulated at late-log phase 
compared  to mid-log phase as well, which was consistent with the Northern blot 
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Fig. 5.4. SDS-PAGE and Western blot analysis of HmuY’ at different growth 
phases. (A) Coomassie blue-stained SDS-PAGE of lysate proteins from P. 
gingivalis W50 grown to mid-log (17h) and late-log (30h) phases. Equal amounts 
of total protein were loaded for each sample. (B) Western blot of P. gingivalis 
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Since transcription and expression of hmuY’ was found to be regulated by late growth 
phase, the effect of hemin concentration on hmuY’ transcription was compared at 
early growth phase (6h) where effect of growth is minimized. hmuY’ transcript was 
found to be slightly upregulated under hemin-limited conditions (Fig. 4.23B). This 
suggests that hmuY’ was also negatively-regulated by hemin levels, i.e. when hemin 
levels were low, transcription of hmuY’ is up-regulated.Taken together, these results 
show that hmuY’ was regulated by both growth phase and hemin availability. 
However, comparing effects of hemin and growth phase on the transcription 
regulation of hmuY’, it was observed that regulation was more significant with the 
growth phase changes as a more significant difference was observed. If hmuY’ was 
tightly regulated by hemin, we would expect the difference between transcripts from 
hemin-limited and hemin-excess conditions to be more significant. 
Although we would expect most genes involved in iron/heme acquisition to be 
regulated by the availability of iron/heme through the ferric uptake regulator (Fur) 
protein, the E. coli Fur consensus could not be identified upstream of the transcript 
start site of hmuY’ (Fig. 4.7). Recently, it has also been reported that regulation of 
gingipains and their involvement in heme utilization may be controlled by other 
mechanisms, which are heme- or iron-independent. Regulation of kgp and rgpA were 
found to be regulated by growth-phase rather than by heme or iron levels (Liu et al., 
2004). kgp and rgpA were down-regulated towards the later phases of growth, which 
was similar to hmuY’. However, a preliminary comparison of the promoter regions of 
kgp, rgpA and hmuY’ did not yield much significant consensus sequences, except for 
the “TTGC” subsequence which was proposed to be a common RNA polymerase 
promoter recognition sequence for the Bacteroidaceae family (section 5.6) (Fig. 5.3). 
Thus further investigations into the promoter region will be required to give a better 
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idea on the regulatory mechanism of hmuY’ and its possible regulatory relationship 
with these gingipains.  
 
5.10 HmuY’ is localized to the outer membrane and is a putative lipoprotein 
HmuY’ was found to possess a hydrophobic N-terminal sequence with a 
putative signal peptide and prokaryotic lipoprotein attachment site, suggesting it is a 
putative lipoprotein (Fig. 4.3). A glycine (Gly) residue was found at the +2 position 
after this cleavage site and is predicted to target lipoprotein to the outer membrane 
(Seydel et al., 1999). This is consistent with the transmission electron microscopy of 
immunogold-labeled HmuY’ (Fig. 4.24), where HmuY’ was found mostly on the 
outer surface of the cells.   
It is also interesting to note that a number of lysine residues were present just 
after the putative signal peptide at amino acids 24-26 of HmuY’. P. gingivalis is 
known to produce a protease known as Kgp that cleaves specifically after lysine 
residues. These Kgp enzymes are known to be involved in post-translational 
modifications of proteases, fimbrillin and outer membrane proteins (Lamont and 
Jenkinson, 1998). Thus, it may be possible that after HmuY’ is targeted to the outer 
membrane surface, Kgp proteases may then cleave the protein and release it into the 
periplasmic or extracellular space for hemin-binding. Cloning and expression of 
HmuY’ in E. coli, with and without the signal peptide, using a C-terminal His-tag also 
resulted in HmuY’ with the signal peptide being present in the insoluble fraction 
while HmuY’ without the signal peptide was highly soluble (results not shown). This  
further suggests the importance of this N-terminus and its role in targeting of this 
putative lipoprotein to the cell outer membrane. Release of lipoproteins by these 
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lysine-specific enzymes has also been suggested for another hemin-binding protein, 
IhtB (Dashper et al., 2000) and Omp28 (Slakeski et al., 2002) from P. gingivalis.  
In P. gingivalis and many other Gram-negative bacteria, iron transport systems 
are usually known to be mediated through a TonB-linked outer membrane receptor 
combined with an inner membrane ABC transport system (Braun, 1995). However, 
there are also various iron uptake systems that consist of only accessory lipoproteins 
coupled with TonB-linked outer membrane receptors. An example is the Tbp1 and 
Tbp2 proteins, which are involved in transferrin uptake in Nessieria meningitidis 
(Legrain et al., 1993). Tbp1 is a TonB-dependent outer membrane receptor while 
Tbp2 codes for an outer membrane accessory lipoprotein. These proteins serve as a 
two-component receptor system to remove iron from transferrin before it is being 
transported to the periplasm (Chen et al., 1993). Another example is the hpuAB 
operon required for haemoglobin-haptoglobin-utilization also present in N. 
meningitidis (Lewis et al., 1997). In this operon, hpuA codes for a lipoprotein and 
hpuB codes for an outer membrane protein which belongs to the TonB family of 
transport proteins. Yet another example is the ihtA-ihtB operon in P. gingivalis 
(Dashper et al., 2000). IhtA is a TonB-linked outer membrane receptor while IhtB is 
an accessory lipoprotein that may function as a chelatase to remove iron from heme 
prior to uptake by P. gingivalis. HmuR was characterized to be a TonB-dependent 
receptor that is able to bind hemin and hemoglobin (Simpson et al., 2000) and HmuY’ 
was found to possess hemin-binding abilities and proposed to be an outer membrane 
lipoprotein important for hemin uptake. Thus, HmuY’ and HmuR may be analogous 
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5.11 Conclusions  
In this study, we have identified a novel ORF, hmuY’, which was found to be 
in-frame but larger than the previously suggested ORF, hmuY. A functional protein of 
24 kDa was shown to be expressed in vivo from this larger ORF through Western blot 
analysis and confirmation with mass spectrometry. Characterization of the putative 
functions of this novel protein was carried out using recombinant protein methods, as 
well as the successful creation of a P. gingivalis isogenic mutant, PgY’1, which is 
deficient in HmuY’. HmuY’ was found to be a hemin-binding protein with a stronger 
hemin-binding ability than HmuY, and HmuY’ was important for the growth of P. 
gingivalis under hemin-limited conditions. Regulation of hmuY’ transcription was 
found to be affected to a greater extent by growth phase changes than by hemin 
concentration. Putative promoter region of hmuY’, in addition to the transcription start 
site, has also been determined. Further, HmuY’ was proposed to be a lipoprotein and 
shown to be localized on the outer surface of P. gingivalis W50 cells. In short, we 
have characterized a novel ORF, hmuY’, in P. gingivalis W50, which is proposed to 
encode an outer membrane protein with hemin-binding properties and plays an 
important role in the growth of this organism.  
 
5.12 Clinical Implications 
Since HmuY’ is found to be important in the hemin uptake and growth of P.  
gingivalis, possible clinical implications may be to produce drugs or therapeutic 
antibodies that target HmuY’. These therapeutics may be important in controlling 
chronic P. gingivalis infections by preventing growth and colonization of P. 
gingivalis. As the focus of this study was the discovery and elucidation of the function 
124 
 
Chapter 5 Discussion 
of the larger HmuY’ protein, these avenues were not explored in this study and will 
likely be the main interest of future studies. 
 
5.13 Future directions 
Although we have proven the existence and characterization of HmuY’ in P. 
gingivalis W50, the prevalence of this gene and its protein in other strains of P. 
gingivalis remains to be determined. It will be interesting to find out if this protein 
was also present in other virulent, non-virulent strains and even clinical samples of P. 
gingivalis in addition to the reasons for their presence or absence. Existence of HmuY 
is also still elusive although the presence of a putative Shine-Dalgarno site upstream 
of the ATG start codon of HmuY suggests the possibility for it to be expressed in vivo. 
Isolation and characterization of the native proteins can be performed using the 
peptide-specific antiserum.  
Interacting partners of HmuY’ can also be investigated using a GST pull-down 
assay with recombinant HmuY’. Of particular interest will be the interaction between 
HmuY’ and HmuR. After the characterization of these proteins separately, 
determining the interactions between these two proteins will give us further insight 
into the hemin-uptake mechanism of P. gingivalis. On a larger scale, 2-D protein gel 
electrophoresis can be used to compare the differences in protein expression between 
the mutant defective in hmuY’ versus the wild type. This will give us an overview of 
the proteins involved in the interactions with HmuY’ and in the uptake of hemin. 
It will also be of significant importance to determine the role of HmuY’ in the 
virulence of P. gingivalis. Mutant PgY’1 and wild type W50 can be used to infect cell 
lines such as those of macrophages and human gingival fibroblasts, and the cytokine 
levels can be measured post-infection to investigate the virulence potential of HmuY’. 
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This can be also be further carried into virulence studies using a mouse model, to 
compare the ability of the mutant, PgY’1, and W50 wild type to cause lesions which is 
an indication of their virulence. Further, antibodies may be raised against recombinant 
HmuY’ and efficacy of these antibodies in targeting P. gingivalis to curb gingival 
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1. Culture media and supplements 
 
All agar and broth media used in this study were sterilized by autoclaving at 121oC 
for 15 min. Plates were prepared by pouring the autoclaved agar-containing media 
into Petri dishes and allowed to solidify. The solidified plates were store at 4oC until 
used. 
 
1.1 P. gingivalis culture media and supplements 
 
(A) BHI (Brain Heart Infusion) modified broth 
    BHI powder (Difco Laboratories)                                                 37.0 g 
    Yeast extract (BBL®, Becton Dickinson & Co.)                             5.0 g 
    Distilled water top up to                                                               1000 ml 
After sterilization by autoclaving, the BHI culture medium was supplemented with 5 
µg/ml hemin, 1 mg/ml L-cysteine and 1 µg/ml menadione and placed in the anaerobic 
chamber (Ruskinn Technology) for overnight reduction prior to use. 
 
(B) Hemin stock solution (1 mg/ml) 
Hemin (Sigma) 10 mg 
1 M NaOH 100 μl 
Dissolve and top up with ddH2O to   10 ml 
Sterilize by autoclaving at 121oC for 15 min. Store at 4oC. 
 
(C) L-cyteine stock solution (100 mg/ml) 
L-cysteine (Sigma)  500 mg 
Distilled water up to       5 ml  
Filter sterilize through a 0.22 μm filter (Millipore) and store in aliquots of 1 ml at -
20oC. 
 
(D) Menadione (Vitamin K) stock solution (5 mg/ml) 
Menadione (Sigma)  15 mg  
95 % ethanol.     3 ml 
Store in aliquots at -20oC. Light-sensitive. 
 
I 
1.2 E. coli Culture Media 
 
(A) LB (Luria-Bertani) broth 
      LB broth powder (Invitrogen)                                                     20.0 g 
      Distilled water top up to                                                             1000 ml 
Store at 4 oC for up to a month. 
 
(B) LB agar 
      LB broth powder (Invitrogen)                                                     20.0 g 
      Agar granulated (BBL®, Becton Dickinson)                               15.0 g 
      Distilled water top up to                                                             1000 ml 
Store at  4 oC for up to a month. 
 
(C) SOC medium 
 Tryptone    4 g 
 Yeast Extract     1 g 
 NaCl 0.1 g 
 KCl (250mM)   2 ml 
 Distilled water to  150 ml 
Adjust pH to 7.0 with 5M NaOH. Top up with ddH2O to 200 ml. Autoclave at 121oC 
for 15 min. Add 4 ml of sterile 1M glucose and 1 ml of sterile 2 M MgCl2. Store in 1 
ml aliquots at -20oC.   
 
1.3 Antibiotic solutions 
 
Antibiotic Stock solution  Working concentration 
Ampicillin  100 mg/ml 100 μg/ml 
Spectinomycin   10 mg/ml   40 μg/ml 
Erythromycin (for P. gingivalis)     5 mg/ml     5 μg/ml 
The antibiotics are all dissolved in ddH2O and filter sterilized through a 0.22 μm 
filter. Aliquots are stored at -20oC. 
II 
2. Buffers and Solutions 
All the buffers and solutions listed below were sterilized by autoclaving at 121oC for 
15 min with the exception of several chemical reagents which were specifically stated. 
Buffers were stored at room temperature unless otherwise stated. 
 
2.1 Common buffers and reagents 
 
(A) 10X PBS buffer 
      NaCl                                                                                            80.0 g 
      KCl                                                                                              2.0 g 
      Na2HPO4                                                                                     14.4 g 
      KH2PO4                                                                                       2.4 g  
      Distilled water                                                                             900 ml 
The pH value was adjusted to 7.4 with concentrated HCl and the volume was then 
topped up to 1000 ml with ddH2O before autoclaving. Solution was diluted to 1X with 
sterile ddH2O before use. 
 
(B) Tris-buffered saline (TBS) 
 Tris base  12.1 g  
 NaCl   9.0 g 
 Distilled water  1000 ml 
Adjust to pH 7.5 with HCl. Store at 4oC up to several months. 
 
(C) 1 M Tris-Cl, pH 9.5 
 Tris base  12.1 g 
 Distilled water  100 ml 
Adjust pH to 9.5 with HCl.  
 
(D) 1 M glucose 
      Glucose                                                                                        18.0 g 
      Distilled water                                                                             100 ml 
The solution was sterilized by filtration through a 0.22 µm filter. 
 
 (E) 250 mM KCl 
      KCl                                                                                              1.86 g 
      Distilled water                                                                             100 ml 
III 
(F) 2 M MgCl2 
      MgCl2·6H2O                                                                                  40.7 g 
      Distilled water top up to                                                                100 ml 
 
(G) 0.5 M Ethylenediamine tetra-acetic acid (EDTA), pH 8.0 
 Na2EDTA·2H2O 18.6 g 
 Distilled water   100 ml 
Adjust to pH 8.0 with NaOH. The disodium EDTA will only go into solution when 
pH is 8.0. 
 
(H) 5 M NaOH 
      NaOH                                                                                           20.0 g 
      Distilled water                                                                             100 ml  
 
(I) 10% and 50 % glycerol 
 10% glycerol 50% glycerol 
      Glycerol                                                              10.0 ml 50.0.ml 
      Distilled water                                                     90.0 ml 50.0 ml 
 
(J) 10% SDS 
      SDS                                                                                              10.0 g 
      Distilled water                                                                             100 ml 
The pH was adjusted to 7.2 with concentrated HCl. Do not autoclave. 
 
2.2 Buffers for agarose gel electrophoresis 
(A) 50X TAE buffer, pH 8.0 
      Tris base                                                                                       242.0 g 
      Glacial acetic acid                                                                        57.1 ml 
      Na2EDTA·2H2O                                                                          37.2 g 
      Distilled water top up to                                                              1000 ml 
Prior to use, the buffer was diluted to 1X with ddH2O. 
 
(B) 6X agarose gel loading buffer 
      Bromophenol blue                                                                        0.063 g 
      Xylene Cyanol FF 0.063 g 
IV 
      FicollTM 400 (Pharmacia)                                                               3.75 g                
      Distilled water top up to                                                               25.0 ml 
 
2.3 Buffers and solutions for SDS-PAGE 
 
(A) 10% Ammonium persulfate (APS) 
      APS                                                                                                 0.1 g 
      Distilled water                                                                                1.0 ml 
Prepare fresh just before use.  
 
(B) 1.5 M Tris-Cl, pH 8.8 
       Tris base   36.3 g 
       Distilled water top up to  200 ml 
Adjust pH to 8.8 with HCl.  
 
(C) 3 M Tris-Cl, pH 6.8 
      Tris base 72.7 g 
      Distilled water top up to                                                               200 ml 
Adjust pH to 6.8 with HCl.  
 
(D) Water-saturated butanol 
 2-butanol 20.0 ml 
 Distilled water 20.0 ml 
 
(E) 6X SDS loading buffer 
      Tris-Cl (1 M, pH 6.8)                                                                   3.0 ml 
      SDS                                                                                              1.2 g 
      Bromophenol blue                                                                       0.006 g 
      Glycerol (100%)                                                                          6.0 ml 
      Distilled water top up to                                                             10.0 ml  
The solution was stored at room temperature and β-mercaptoethanol was freshly 






(F) 5X Tris-glycine running buffer 
      Tris base                                                                                      15.1g 
      Glycine                                                                                        94.0 g 
      SDS (10%)                                                                                  50.0 ml 
      Distilled water top up to                                                             1000 ml 
Buffer was diluted to 1X with distilled water prior to use. 
 
(G) Composition of gels for SDS-PAGE 
  (i) 4% stacking gel 
 30% Acrylamide/ Bis solution, 37.5:1 (Bio-Rad) 400 μl 
 1 M Tris-Cl (pH 6.8) 375 μl 
 10% SDS   30 μl 
 10% APS   30 μl 
 Temed (Sigma)    4 μl 
 Distilled water up to    3 ml  
(ii) 12% resolving gel 
 30% Acrylamide/ Bis solution, 37.5:1 (Bio-Rad) 2.0 ml 
 3 M Tris-Cl (pH 8.8) 625 μl 
 10% SDS   50 μl 
 10% APS   50 μl 
 Temed (Sigma)     4 μl 
 Distilled water up to     5 ml 
 
2.4 Buffers and solutions for protein expression and purification 
 
(A) 100 mM IPTG 
      IPTG                                                                                             240 mg 
      Distilled water                                                                               10 ml 
The solution was filter-sterilized by passing it through a 0.22 µm filter and stored in 
small aliquots at -20oC. 
 
(B) Lysozyme solution (10 mg/ml) 
 Lysozyme  50 mg 
 1 M Tris-Cl, pH 8.0 125 μl 
VI 
 Distilled water to  5 ml 
Store in aliquots at -20oC. 
 
(C) Elution buffer, pH 8.0 
      Tris-Cl                                                                                          50 mM 
      Reduced glutathione                                                                    10 mM 
The pH value was adjusted to 8.0 with 10 mM NaOH and stored at -20oC in small 
aliquots until needed. Avoid more than five freeze/thaw cycles. 
  
(D) Thrombin solution  
 Thrombin (GE Healthcare) 500 units 
 1X PBS (ice-cold)   0.5 ml 
Store in small aliquots at -80oC. 
 
2.5 Buffers for Western blot 
 (A) Transfer buffer 
       Tris base                                                                                      5.8 g 
       Glycine                                                                                        2.9 g 
       SDS                                                                                             0.37 g 
       Methanol                                                                                     200 ml 
       Distilled water top up to                                                             1000 ml 
The pH value was adjusted to 8.3. 
 
(B) Blocking buffer 
 Non-fat skim milk (Bio-Rad)    5 g 
 Tween 20  1.0 ml 
 TBS 1000 ml 
Prepare just before use. 
(C) Wash buffer (TTBS)  
 Tween 20 (ICN Biomedicals)    1.0 ml 
 TBS 1000 ml 
Store up to several months at 4oC. 
 
(D) Alkaline phosphate buffer  
 1 M Tris-Cl (pH 9.5) 10 ml  
VII 
  NaCl  0.59 g  
 2 M MgCl2 250 μl 
 Distilled water up to  100 ml 
 
(E) Ponceau S solution 
 Ponceau S 0.5 g 
 Glacial acetic acid 1 ml 
 Distilled water to 100 ml 
 
2.6 Buffers for LDS-PAGE and TMBZ staining 
 
 (A) 10% LDS 
     Lithium dodecyl sulphate (LDS) (Sigma)                                    1.0 g 
      Distilled water                                                                             10 ml 
 
(E) 5X LDS loading buffer 
      Tris-Cl (1 M, pH 6.8)                                                                   3.0 ml 
      LDS (20 %)                                                                                  6.0 ml 
      Bromophenol blue                                                                       0.006 g 
      Glycerol (100%)                                                                          6.0 ml 
      Distilled water top up to                                                             10.0 ml  
 
(B) 5X LDS-PAGE running buffer 
      Tris base                                                                                      15.1g 
      Glycine                                                                                        94.0 g 
      LDS (10%)                                                                                  50.0 ml 
      Distilled water top up to                                                             1000 ml 
(C) Composition of LDS-PAGE gels 
(i) 4% stacking gel 
 30% Acrylamide/ Bis solution, 37.5:1 (Bio-Rad) 400 μl 
 1 M Tris-Cl (pH 6.8) 375 μl 
 10% LDS   30 μl 
 10% APS   30 μl 
 500 mM EDTA   12 μl 
 Temed (Sigma)     4 μl 
VIII 
 Distilled water up to     3 ml  
(ii) 12% resolving gel 
 30% Acrylamide/ Bis solution, 37.5:1 (Bio-Rad) 2.0 ml 
 3 M Tris-Cl (pH 8.8) 625 μl 
 10% LDS   50 μl 
 10% APS   50 μl 
 Temed (Sigma)     4 μl 
 Distilled water up to     5 ml 
 
(D) Sodium acetate (0.25M, pH 5.0) 
 Sodium acetate   20.5 g 
 Distilled water to 1000ml 
Adjust to pH 5.0 with glacial acetic acid.  
 
(E) Tetramethylbenzidine (TMBZ) solution 
 3,3’,5,5’-Tetramethylbenzidine (Fluka) 0.016 g 
 Methanol 20 ml 
Prepare fresh prior to use. Light-sensitive. 
 
2.7 Buffers for Southern blot 
  
(A) Denaturation solution  
 5 M NaOH   50 ml 
 NaCl     44 g 
 Distilled water up to  500 ml 
(B) Neutralization solution 
 1 M Tris-Cl (pH 7.5) 250 ml 
 NaCl   44 g 
 Distilled water up to  500 ml 
 
(C) 20X SSC (sodium chloride/sodium citrate) 
 NaCl 175 g 
 Na3citrate·2H2O  88 g 
 Distilled water to  1000 ml 
Adjust to pH 7.0 with HCl. 
 
IX 
2.8 Buffers for Northern blot 
 
(A) Northern Transfer Buffer  
 20X SSC 125 ml 
 5 M NaOH  1.0 ml 
 DEPC-treated water up to  500 ml 
 
(B) 10 mM EDTA 
 0.5 M EDTA, pH 8.0 (RNAse-free, Ambion)   0.2 ml 
 DEPC-treated water up to 10.0 ml 
 
(C) Low Stringency Wash Solution (2X SSC, 0.1% SDS) 
 20X SSC (prepared in DEPC-treated water)   100 ml 
 10% SDS (prepared in DEPC-treated water)     10 ml 
 DEPC-treated water up to 1000 ml 
  
(D) High Stringency Wash Solution (0.1X SSC, 0.1% SDS) 
 20X SSC (prepared in DEPC-treated water)    5.0 ml 
 10% SDS (prepared in DEPC-treated water)     10 ml 
 DEPC-treated water up to 1000 ml 
 
2.9 Solution for electroporation of P. gingivalis 
(A) Electroporation (EP) Buffer 
 Glycerol    50 ml 
 2M MgCl2 0.25 ml 
Distilled water up to  500 ml 
Sterilize by autoclaving and pre-chill to 4oC before use. 
 
2.10 Solutions for transmission electron microscopy 
 
(A) Double Strength Primary Fixative 
 Paraformaldehyde  2 ml 
 Glutaraldehyde 0.25 ml 
 Top up with 1X PBS to 50 ml 
To obtain single strength Primary Fixative, dilute the above in an equal volume of 1X 
PBS. Store at 4oC. 
 
X 
(B) Uranyl acetate 
 Uranyl acetate (Sigma)     4 g  
 70 % ethanol.  100 ml 
The solution is stored in a glass-stoppered bottle and kept at 4 °C. 
 
(C) Lead citrate 
 
 Lead nitrate (BDH)    1.33 g 
 Sodium citrate (BDH)  1.76 g 
 Distilled water  30 ml 
Dissolve the above with shaking. After 30 min of shaking, 8 ml of 1 M NaOH was 
added and the pH adjusted to 12.0. Another 50 ml of ddH2O was used to top up the 
solution. The solution was then centrifuged at 2000 rpm for 5 min. The clear 





1a ) Mascot search results for 24 kDa band (Result of top hit): 
    
   Observed  Mr(expt)  Mr(calc)   Delta Start  End 
Miss
 Ions Peptide 
 823.50  822.49  822.49  0.00 104 - 109 1  ---  RVFFVR 
 1388.74  1387.74  1387.74  -0.00 131 - 142 0  ---  GVITFTYTYPVK 
 1397.70  1396.70  1396.64  0.06 6 - 17 1  ---  YDVRLNCGESGK 
 1456.71  1455.70  1455.69  0.01 118 - 129 0  ---  VQFTDYQDAELK 
 1516.82  1515.81  1515.83  -0.02 130 - 142 1  ---  KGVITFTYTYPVK 
 1584.79  1583.79  1583.78  0.00 118 - 130 1  ---  VQFTDYQDAELKK 
 1584.79  1583.79  1583.78  0.00 118 - 130 1  46  VQFTDYQDAELKK 
 2269.05  2268.05  2268.06  -0.01 28 - 48 0  ---  TEMDQATTVPTDGYTVDVLGR 
 2269.05  2268.05  2268.06  -0.01 28 - 48 0  160  TEMDQATTVPTDGYTVDVLGR 
 2285.11  2284.10  2284.05  0.05 28 - 48 0  ---  TEMDQATTVPTDGYTVDVLGR + Oxidation (M) 
 2379.09  2378.08  2378.11  -0.03 78 - 100 0  ---  NAQGFASGGWLEFSHGPAGPTYK 
 2379.09  2378.08  2378.11  -0.03 78 - 100 0  141  NAQGFASGGWLEFSHGPAGPTYK 
 2761.13  2760.13  2760.17  -0.04 53 - 76 0  ---  YEMGPDGHQMEYEEQGFSEVITGK 
 2777.16  2776.15  2776.16  -0.01 53 - 76 0  ---  YEMGPDGHQMEYEEQGFSEVITGK + Oxidation (M) 
 2793.16  2792.15  2792.16  -0.00 53 - 76 0  ---  YEMGPDGHQMEYEEQGFSEVITGK + 2 Oxidation (M) 
 2921.31  2920.31  2920.25  0.05 53 - 77 1  ---  YEMGPDGHQMEYEEQGFSEVITGKK + 2 Oxidation (M) 
1.  
   gi|34541209       Mass: 15610    Score: 449    Expect: 4.1e-039  Peptides matched: 16 
  hmuY protein [Porphyromonas gingivalis W83] 
No match to: 856.54, 868.56, 870.55, 1108.58, 1123.57, 1126.55, 1165.60, 1302.65, 1365.68, 1384.65, 1384.65, 
1400.64, 1400.64, 1416.61, 1475.77, 1485.67, 1485.67, 1512.73, 1537.64, 1539.68, 1640.82, 1707.78, 1766.79, 
1769.86, 1794.82, 1794.82, 1818.85, 1861.88, 1861.88, 1987.07, 1993.97, 2083.01, 2195.70, 2221.07, 2223.15, 
2230.19, 2267.14, 2283.16, 2283.16, 2297.16, 2300.15, 2368.20, 2408.03, 2411.07, 2420.19, 2437.13, 2537.15, 
2564.15, 2663.34, 2714.15, 2720.25, 2748.26, 2914.46, 3077.58, 3094.59, 3106.40, 3346.62, 3349.56, 3355.68 X
II 
1b ) Mascot search results for 24 kDa band (Protein view of peptide coverage): 
 
Match to: gi|34541209 Score: 449 Expect: 4.1e-039 
hmuY protein [Porphyromonas gingivalis W83] 
 
Nominal mass (Mr): 15610; Calculated pI value: 6.84 
NCBI BLAST search of gi|34541209 against nr 
Unformatted sequence string for pasting into other applications 
 
Taxonomy: Porphyromonas gingivalis W83
Links to retrieve other entries containing this sequence from NCBI Entrez: 
gi|6409428 from Porphyromonas gingivalis
gi|34397525 from Porphyromonas gingivalis W83
 
Fixed modifications: Carbamidomethyl (C) 
Variable modifications: Oxidation (M) 
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 78% 
 
Matched peptides shown in Bold Red 
 
     1 MALHRYDVRL NCGESGKGKG GAVFSGKTEM DQATTVPTDG YTVDVLGRIT  
    51 VKYEMGPDGH QMEYEEQGFS EVITGKKNAQ GFASGGWLEF SHGPAGPTYK  
   101 LSKRVFFVRG ADGNIAKVQF TDYQDAELKK GVITFTYTYP VK 
 
Start - End   Observed  Mr(expt) Mr(calc)   Delta   Miss Sequence 
     6 - 17     1397.70  1396.70  1396.64     0.06     1  YDVRLNCGESGK  (No match) 
    28 - 48     2269.05  2268.05  2268.06    -0.01     0  TEMDQATTVPTDGYTVDVLGR  (No match) 
    28 - 48     2269.05  2268.05  2268.06    -0.01     0  TEMDQATTVPTDGYTVDVLGR  (Ions score 160) 
    28 - 48     2285.11  2284.10  2284.05     0.05     0  TEMDQATTVPTDGYTVDVLGR  Oxidation (M) (No match) 
    53 - 76     2761.13  2760.13  2760.17    -0.04     0  YEMGPDGHQMEYEEQGFSEVITGK  (No match) 
    53 - 76     2777.16  2776.15  2776.16    -0.01     0  YEMGPDGHQMEYEEQGFSEVITGK  Oxidation (M) (No match) 
    53 - 76     2793.16  2792.15  2792.16    -0.00     0  YEMGPDGHQMEYEEQGFSEVITGK  2 Oxidation (M) (No match) 
    53 - 77     2921.31  2920.31  2920.25     0.05     1  YEMGPDGHQMEYEEQGFSEVITGKK  2 Oxidation (M) (No match) 
    78 - 100    2379.09  2378.08  2378.11    -0.03     0  NAQGFASGGWLEFSHGPAGPTYK  (No match) 
    78 - 100    2379.09  2378.08  2378.11    -0.03     0  NAQGFASGGWLEFSHGPAGPTYK  (Ions score 141) X
III Cont’d next page… 
 Cont’d from previous page…. 
 
  Start - End   Observed  Mr(expt) Mr(calc)   Delta   Miss Sequence 
   104 - 109     823.50   822.49   822.49     0.00     1  RVFFVR  (No match) 
   118 - 129    1456.71  1455.70  1455.69     0.01     0  VQFTDYQDAELK  (No match) 
   118 - 130    1584.79  1583.79  1583.78     0.00     1  VQFTDYQDAELKK  (No match) 
   118 - 130    1584.79  1583.79  1583.78     0.00     1  VQFTDYQDAELKK  (Ions score 46) 
   130 - 142    1516.82  1515.81  1515.83    -0.02     1  KGVITFTYTYPVK  (No match) 






2) PeptideMass prediction results of HmuY’ protein: 
PeptideMass 
The entered sequence is: 
        10         20         30         40         50         60  
MKKIIFSALC ALPLIVSLTS CGKKKDEPNQ PSTPEAVTKT VTIDASKYET WQYFSFSKGE  
 
        70         80         90        100        110        120  
VVNVTDYKND LNWDMALHRY DVRLNCGESG KGKGGAVFSG KTEMDQATTV PTDGYTVDVL  
 
       130        140        150        160        170        180  
GRITVKYEMG PDGHQMEYEE QGFSEVITGK KNAQGFASGG WLEFSHGPAG PTYKLSKRVF  
 
       190        200        210  
FVRGADGNIA KVQFTDYQDA ELKKGVITFT YTYPVK  
The selected enzyme is: Trypsin  
Maximum number of missed cleavages (MC): 0  
All cysteines have been treated with Iodoacetamide to form carbamidomethyl-cysteine (Cys_CAM).  
Methionines have not been oxidized.  
Displaying peptides with a mass bigger than 500 Dalton.  
Using monoisotopic masses of the occurring amino acid residues and giving peptide masses as [M+H]+. 
Cont’d next page… X
V
 
Cont’d from previous page… 
The peptide masses from your sequence are: 
[Theoretical pI: 6.83 / Mw (average mass): 23879.00 / Mw (monoisotopic mass): 23863.86]  
mass position #MC artif.modification(s) modifications peptide sequence
2761.1756 127-150 0    
 
  
 YEMGPDGHQMEYEEQGFSEV ITGK 
2379.1152 152-174 0    
 
  
 NAQGFASGGWLEFSHGPAGP TYK 
2269.0652 102-122 0    
 
  
 TEMDQATTVPTDGYTVDVLG R 
2049.1486 4-23 0 Cys_CAM: 10, 21 2163.1915 
 
  
 IIFSALCALPLIVSLTSCGK  




























I Cont’d next page… 
Cont’d from previous page… 


























Note: Peptides masses and the sequences of those matching HmuY’ (other than those similar to HmuY) are indicated in blue. 
92.1% of sequence covered (you may modify the input parameters to display also peptides < 500 Da):  
        10         20         30         40         50         60  
mkkIIFSALC ALPLIVSLTS CGKkkDEPNQ PSTPEAVTKT VTIDASKYET WQYFSFSKGE  
 
        70         80         90        100        110        120  
VVNVTDYKND LNWDMALHRY DVRLNCGESG KgkGGAVFSG KTEMDQATTV PTDGYTVDVL  
 
       130        140        150        160        170        180  
GRitvkYEMG PDGHQMEYEE QGFSEVITGK kNAQGFASGG WLEFSHGPAG PTYKlskrVF  
 
       190        200        210  
FVRGADGNIA KVQFTDYQDA ELKkGVITFT YTYPVK  
 XV
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Introduction
Porphyromonas gingivalis is a black-pigmented, Gram-negative anaerobic bacterium which is a major 
etiological agent in the development of severe and chronic periodontitis. This organism has an essential 
requirement for iron, which is preferred in the form of heme, for its growth and virulence. Since genes 
required for the synthesis of protoporphyrin IX, a precursor of heme, are absent in P. gingivalis, it has 
evolved various strategies for the uptake of extra-cellular heme. In this study, we have characterized a novel 
24kDa protein which is important in the uptake of hemin for the growth of this organism.  
Results and Discussion
1. Discovery of hmuX 2.  Recombinant HmuX 
demonstrates hemin-binding ability.
3.  Characterization of a   
P. gingvalis hmuX mutant
4.  Transcription 
regulation of hmuX
5.  Localization of HmuX
Fig 2. LDS-PAGE of purified rHmuX fusion 
protein, stained in Coomassie-blue (Left) and
in tetramethylbenzidine (TMBZ) (Right). TMBZ 
allows for detection of peroxidase activity  of 
hemin-bound proteins. Arrow indicates 
increased peroxidase activity as a result of 
hemin bound to HmuX. GST alone shows 
negative hemin-binding. Lanes 1, GST-HmuX 
with hemin; Lanes 2, GST with hemin; Lane 3, 
GST-HmuX without hemin. 
Fig. 3(A) (1)SDS-PAGE and (2) Western 
blot analysis of P. gingivalis W50 and 
mutant Pg∆X1 using HmuY anti-serum.  (B) 
Growth of P. gingivalis W50 and Pg∆X1 
mutant under hemin-excess (5ug/ml) and 
hemin-limited (0ug/ml) conditions. 
Fig. 4. Northern blot 
analyses of hmuX at early-
log (6h), mid-log (17h) and 
late-log (30h) phase under 
hemin-excess (5 ug/ml) 
and hemin-limited (0 
ug/ml) conditions. 16S 
rRNA was used as the 
loading control.
Western blot analysis of 
P. gingivalis using 
HmuY peptide-specifc
anti-serum detected a 
24kDa protein band 
instead of the expected 
16kDa (See Fig. 3A). 
Mass spectrometry 
confirmed this band to 
be similar to HmuY
(data not shown). 
Sequence analysis 
revealed a start codon
upstream of putative 
hmuY and in-frame with 
the hmuY stop codon, 
which gives rise to a 
predicted 24kDa protein. 
We designated this new 
gene as hmuX (Fig.1).
P. gingivalis mutant , PgΔX1, deficient in 
HmuX showed decreased ability to survive 
under hemin-limited conditions compared 
to the wild type. This shows importance of 
HmuX in hemin uptake in vivo.
hmuX was upregulated under 
hemin-limited conditions 
throughout all growth phases.
Fig. 1 Complete nucleotide and amino acid 
sequence of hmuX. SD, Shine-Dalgarno
site. Putative lipoprotein attachment site is 
highlighted in grey.
Fig. 5. Transmission electron micrograph of P. 
gingivalis W50 cells at 60000x magnification. 
Arrows indicate immunogold-labeled HmuX 
localized mainly to the outer envelope, which is 
consistent with it being a lipoprotein.
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HmuX is a novel 24kDa hemin-binding 
protein which is localized  to the outer 
membranes and is important in the uptake 
of hemin for the growth of P. gingivalis.
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